>PA576963.1 WO 2023026994-A/11: Human transferrin receptor binding peptide-drug conjugate
CTCAGAAAGACAC
>OO465486.1 Sequence 16 from patent US 11421038
GCCGCCACCATGG
>OO342985.1 Sequence 55 from patent US 11389479
CGCTTAACCTCCC
>OO342728.1 Sequence 15 from patent US 11388871
AACGGCGACATCG
>OO342727.1 Sequence 14 from patent US 11388871
AACGGCAACATCG
>OO313419.1 Sequence 13 from patent US 11376286
TWCANNNNNNTGG
>OO312989.1 Sequence 11 from patent US 11376238
CAGAGCAAGGACG
>OO296444.1 Sequence 13 from patent US 11369691
GCCGCCACCATGG
>OO497797.1 Sequence 72 from patent US 11427865
AGCNGCCGCGGTA
>OO497796.1 Sequence 71 from patent US 11427865
AGCMGCCGCGGTA
>OO497791.1 Sequence 66 from patent US 11427865
GCNGCCGCGGTAA
>OO497790.1 Sequence 65 from patent US 11427865
GCMGCCGCGGTAA
>OO497787.1 Sequence 62 from patent US 11427865
GTGNCAGCNGCCG
>OO497786.1 Sequence 61 from patent US 11427865
GTGYCAGCMGCCG
>OO497672.1 Sequence 30 from patent US 11427864
TGGGCGGGCCAAA
>OO497664.1 Sequence 22 from patent US 11427864
GGCATGAGCTGCG
>OO477484.1 Sequence 1182 from patent US 11427837
AGGGTGGGCAACC
>OO477437.1 Sequence 1110 from patent US 11427837
TGAGAAGTGGCAC
>OO476405.1 Sequence 43 from patent US 11427829
TTTTTTTTCTCTT
>OO473290.1 Sequence 542 from patent US 11427800
GCCGCCRCCATGG
>OO470896.1 Sequence 7 from patent US 11421274
GAACNNNNNNTAC
>OO470894.1 Sequence 5 from patent US 11421274
GAAGNNNNNNTAC
>OO470893.1 Sequence 4 from patent US 11421274
GAACNNNNNNTCC
>OO470890.1 Sequence 1 from patent US 11421274
GGCCNNNNNGGCC
>OO468361.1 Sequence 136 from patent US 11421238
TGCTCATACCAAT
>OO468360.1 Sequence 135 from patent US 11421238
GAAGCCAGATGGT
>OO468359.1 Sequence 134 from patent US 11421238
CCTCAAGCGGACT
>OO468358.1 Sequence 133 from patent US 11421238
GAACGGCGAACGC
>OO468357.1 Sequence 132 from patent US 11421238
TCGGCAAGGCGAG
>OO468356.1 Sequence 131 from patent US 11421238
CGTCAGGCTTGAC
>OO468355.1 Sequence 130 from patent US 11421238
GATCCGGTTGCAA
>OO468354.1 Sequence 129 from patent US 11421238
CTGCGATCCGGCC
>OO468353.1 Sequence 128 from patent US 11421238
GATTCGGAATACT
>OO468352.1 Sequence 127 from patent US 11421238
GATCTCCGATATA
>OO468351.1 Sequence 126 from patent US 11421238
GGCATCGATGGAC
>OO468350.1 Sequence 125 from patent US 11421238
GAGGTCTCGGAGG
>OO468349.1 Sequence 124 from patent US 11421238
CGGATCTGGTATA
>OO468348.1 Sequence 123 from patent US 11421238
TTAAGGTACTGCT
>OO468347.1 Sequence 122 from patent US 11421238
AGGTAGATATTCG
>OO468346.1 Sequence 121 from patent US 11421238
TATACGGCGACCT
>OO468345.1 Sequence 120 from patent US 11421238
GCCGGAGTCCTCG
>OO468344.1 Sequence 119 from patent US 11421238
GTCGAAGATAAGG
>OO468343.1 Sequence 118 from patent US 11421238
ACGCTCATAGCCT
>OO468342.1 Sequence 117 from patent US 11421238
CTTCGTCTCTACG
>OO468341.1 Sequence 116 from patent US 11421238
GCCTTGCTACTGG
>OO468340.1 Sequence 115 from patent US 11421238
CTCCAACTAACGT
>OO468339.1 Sequence 114 from patent US 11421238
AGAGATGCGATCG
>OO468338.1 Sequence 113 from patent US 11421238
ATGGAATAGGCGA
>OO468337.1 Sequence 112 from patent US 11421238
AGATGCGGTTAAC
>OO468336.1 Sequence 111 from patent US 11421238
TGCCTGAGAACGT
>OO468335.1 Sequence 110 from patent US 11421238
TCGGTTATAAGTC
>OO468334.1 Sequence 109 from patent US 11421238
TAATTGGTTATCT
>OO468333.1 Sequence 108 from patent US 11421238
ATGGCGCCGCGCA
>OO468332.1 Sequence 107 from patent US 11421238
GTCTGCTACGCTT
>OO468331.1 Sequence 106 from patent US 11421238
CTTAGCCGAGAGA
>OO468330.1 Sequence 105 from patent US 11421238
ATTCCGAGGAAGA
>OO468329.1 Sequence 104 from patent US 11421238
GTTCATCTCTTCC
>OO468328.1 Sequence 103 from patent US 11421238
GTTCTGGTTCGCT
>OO468327.1 Sequence 102 from patent US 11421238
TTCCTAATTCCAA
>OO468326.1 Sequence 101 from patent US 11421238
GAGTTAGTAAGTT
>OO468325.1 Sequence 100 from patent US 11421238
AATGGAAGGACCG
>OO468324.1 Sequence 99 from patent US 11421238
AAGCGGTCCTCTT
>OO468323.1 Sequence 98 from patent US 11421238
CAACTGAATTAGG
>OO468322.1 Sequence 97 from patent US 11421238
TTGCCTAGCGAGG
>OO468321.1 Sequence 96 from patent US 11421238
CTGCATGAGGTTG
>OO468320.1 Sequence 95 from patent US 11421238
TAAGCTACCAGCG
>OO468319.1 Sequence 94 from patent US 11421238
TTCTCTCTGCAGG
>OO468318.1 Sequence 93 from patent US 11421238
GCAGTTCGAACGC
>OO468317.1 Sequence 92 from patent US 11421238
GCCGCAGATTACG
>OO468316.1 Sequence 91 from patent US 11421238
TCCAACGCGCGTT
>OO468315.1 Sequence 90 from patent US 11421238
GGCCATTCTCCAG
>OO468314.1 Sequence 89 from patent US 11421238
TAGAATTGGCCTC
>OO468313.1 Sequence 88 from patent US 11421238
CAGAGAAGGCGCA
>OO468312.1 Sequence 87 from patent US 11421238
TTCGCTCAAGTAT
>OO468311.1 Sequence 86 from patent US 11421238
TTCTAGAGATACC
>OO468310.1 Sequence 85 from patent US 11421238
AACCGCGAGGCTC
>OO468309.1 Sequence 84 from patent US 11421238
TGCTATTCCAGGC
>OO468308.1 Sequence 83 from patent US 11421238
GGTAACTCCATAT
>OO468307.1 Sequence 82 from patent US 11421238
AGAGAAGTCGAGT
>OO468306.1 Sequence 81 from patent US 11421238
TGCGAGATCGAAG
>OO468305.1 Sequence 80 from patent US 11421238
CCATAGTTATGGT
>OO468304.1 Sequence 79 from patent US 11421238
GCTCTTAGTATCC
>OO468303.1 Sequence 78 from patent US 11421238
CAATCTATTCTGA
>OO468302.1 Sequence 77 from patent US 11421238
GAGAGTCCATGAT
>OO468301.1 Sequence 76 from patent US 11421238
GGAGAGTTACCTC
>OO468300.1 Sequence 75 from patent US 11421238
GCAGCATGCCGAT
>OO468299.1 Sequence 74 from patent US 11421238
AATGCTATTATCC
>OO468298.1 Sequence 73 from patent US 11421238
CAGATACGTAGAG
>OO468297.1 Sequence 72 from patent US 11421238
TTGGCCAGTCGCT
>OO468296.1 Sequence 71 from patent US 11421238
GCTCGGCGTTCGA
>OO468295.1 Sequence 70 from patent US 11421238
TTATGGAGCAATA
>OO468294.1 Sequence 69 from patent US 11421238
CCATACGATCAGG
>OO468293.1 Sequence 68 from patent US 11421238
TGGAATTCTCCAA
>OO468292.1 Sequence 67 from patent US 11421238
ACTTAATCGTACT
>OO468291.1 Sequence 66 from patent US 11421238
CCATCAGACCTCT
>OO468290.1 Sequence 65 from patent US 11421238
ACGTCTCTAGGAG
>OO468289.1 Sequence 64 from patent US 11421238
AAGGCGACTCCGA
>OO468288.1 Sequence 63 from patent US 11421238
AAGCAATAATAAT
>OO468287.1 Sequence 62 from patent US 11421238
ATCTCTCTTAGCA
>OO468286.1 Sequence 61 from patent US 11421238
CAGCGGACGCGCT
>OO468285.1 Sequence 60 from patent US 11421238
GTACTCCATCCAA
>OO468284.1 Sequence 59 from patent US 11421238
AGGCCTCTCTACC
>OO468283.1 Sequence 58 from patent US 11421238
GGTCGTATGCGTA
>OO468282.1 Sequence 57 from patent US 11421238
CCTGAACTCAAGT
>OO468281.1 Sequence 56 from patent US 11421238
TGCATCCGCGCTT
>OO468280.1 Sequence 55 from patent US 11421238
GAGTTCTCCAGAT
>OO468279.1 Sequence 54 from patent US 11421238
CCGAAGACGTCAT
>OO468278.1 Sequence 53 from patent US 11421238
AACGCCTAGCCGA
>OO468277.1 Sequence 52 from patent US 11421238
TATCCTGAGCGAT
>OO468276.1 Sequence 51 from patent US 11421238
TTGACTCTCGCGC
>OO468275.1 Sequence 50 from patent US 11421238
CAGCTTCATAGCG
>OO468274.1 Sequence 49 from patent US 11421238
CCTTCTCAGTCCG
>OO468273.1 Sequence 48 from patent US 11421238
TCCTCTGCGCTGC
>OO468272.1 Sequence 47 from patent US 11421238
CTCCTCATCTTCC
>OO468271.1 Sequence 46 from patent US 11421238
TACTAGCAGAGAT
>OO468270.1 Sequence 45 from patent US 11421238
ACGAATGATGCTC
>OO468269.1 Sequence 44 from patent US 11421238
CCTGCATTATTCG
>OO468268.1 Sequence 43 from patent US 11421238
GACGTATTAGAGC
>OO468267.1 Sequence 42 from patent US 11421238
TACTGCATCTCGT
>OO468266.1 Sequence 41 from patent US 11421238
GTCGAAGAAGTCC
>OO468265.1 Sequence 40 from patent US 11421238
AATAGGTAGTACG
>OO468264.1 Sequence 39 from patent US 11421238
TCTGAGTAGCCGG
>OO468263.1 Sequence 38 from patent US 11421238
GAGATGAGAAGAA
>OO468262.1 Sequence 37 from patent US 11421238
ATTGAATACTCTG
>OO468261.1 Sequence 36 from patent US 11421238
CCTCCATTAGAGA
>OO468260.1 Sequence 35 from patent US 11421238
TATGACGGATCCG
>OO468259.1 Sequence 34 from patent US 11421238
ACGCCAAGGCGTA
>OO468258.1 Sequence 33 from patent US 11421238
ACCTAGATATGGA
>OO468257.1 Sequence 32 from patent US 11421238
GCAAGGCATAGTA
>OO468256.1 Sequence 31 from patent US 11421238
TTAGCATTCTCTT
>OO468255.1 Sequence 30 from patent US 11421238
GACGGCTAACTCC
>OO468254.1 Sequence 29 from patent US 11421238
CTTCGAGACTTAC
>OO468253.1 Sequence 28 from patent US 11421238
ACGCGTAGAAGAG
>OO468252.1 Sequence 27 from patent US 11421238
AGGATCAGGCTAC
>OO468251.1 Sequence 26 from patent US 11421238
GAATTACCTCGTT
>OO468250.1 Sequence 25 from patent US 11421238
TAGACTGGAACTT
>OO468249.1 Sequence 24 from patent US 11421238
GGACCTGCATGAA
>OO468248.1 Sequence 23 from patent US 11421238
GATGGAACTCAGC
>OO468247.1 Sequence 22 from patent US 11421238
ATACGACTCGGAG
>OO468246.1 Sequence 21 from patent US 11421238
TATGCCATGAGGA
>OO468245.1 Sequence 20 from patent US 11421238
CGGAGCGCTTATT
>OO468244.1 Sequence 19 from patent US 11421238
GTCTATGAACCAA
>OO468243.1 Sequence 18 from patent US 11421238
GTTCTCATAGGTA
>OO468242.1 Sequence 17 from patent US 11421238
CTATCTTGCTGGT
>OO468241.1 Sequence 16 from patent US 11421238
GCCAATATCAAGT
>OO468240.1 Sequence 15 from patent US 11421238
GTAGGTTCTACTG
>OO468239.1 Sequence 14 from patent US 11421238
TCTACTAGTACGA
>OO468238.1 Sequence 13 from patent US 11421238
TTGCAGCCTCTAA
>OO468237.1 Sequence 12 from patent US 11421238
CGCGAACCGTTAG
>OO468236.1 Sequence 11 from patent US 11421238
TTCGCGCTTGGAC
>OO468235.1 Sequence 10 from patent US 11421238
GTCATCTGCGACC
>OO468234.1 Sequence 9 from patent US 11421238
TGGCCATAGCTAC
>OO468233.1 Sequence 8 from patent US 11421238
TAGAATTGAAGAA
>OO455308.1 Sequence 14 from patent US 11414667
TGTCCGCTCCTCG
>OO455307.1 Sequence 13 from patent US 11414667
TGTCCGCTCCTCG
>OO452611.1 Sequence 3209 from patent US 11413346
GCCGCCACCATGG
>OO452610.1 Sequence 3208 from patent US 11413346
GCCGCCACCATGG
>OO449575.1 Sequence 81 from patent US 11408095
GGCCATTACGGCC
>OO449446.1 Sequence 5355 from patent US 11408034
TGCTGGCCGTCCA
>OO448573.1 Sequence 4482 from patent US 11408034
CATCCCGCGCCAC
>OO448572.1 Sequence 4481 from patent US 11408034
CATCCCGCGCCAT
>OO448402.1 Sequence 4311 from patent US 11408034
TGCGGCTCCACCA
>OO415985.1 Sequence 54 from patent US 11401558
CATGTCTCGGGAA
>OO415984.1 Sequence 53 from patent US 11401558
TTCCCGAGACATG
>OO413165.1 Sequence 20 from patent US 11401526
TGAATGCATGATC
>OO413120.1 Sequence 136 from patent US 11401524
AACGGCTGAAGGC
>OO413118.1 Sequence 134 from patent US 11401524
CTGGAGGCAAATC
>OO413115.1 Sequence 131 from patent US 11401524
CCAGGGAACTTTT
>OO413103.1 Sequence 119 from patent US 11401524
CAAGTGGGCTGCC
>OO413089.1 Sequence 105 from patent US 11401524
CTGGACGCAAATC
>OO413082.1 Sequence 98 from patent US 11401524
CGATGGAAAAATT
>OO413079.1 Sequence 95 from patent US 11401524
TCCCCGGGTCTGG
>OO413074.1 Sequence 90 from patent US 11401524
CAAGTCGGCTGCC
>OO412937.1 Sequence 91 from patent US 11401522
TTTTTTTTCTCTT
>OO411165.1 Sequence 2465 from patent US 11401346
GGCCNNNNNGGCC
>OO410050.1 Sequence 630 from patent US 11400169
CCAGNNNNNNCTC
>OO410049.1 Sequence 629 from patent US 11400169
GAGNNNNNNCTGG
>OO410048.1 Sequence 628 from patent US 11400169
WCGNNNNNNNCGW
>OO410045.1 Sequence 625 from patent US 11400169
GAAGNNNNNNTAC
>OO410042.1 Sequence 622 from patent US 11400169
GACNNNNNNTTYG
>OO409908.1 Sequence 64 from patent US 11400169
NNNNNNNNTCTTC
>OO409907.1 Sequence 63 from patent US 11400169
GAAGANNNNNNNN
>OO409904.1 Sequence 57 from patent US 11400169
GGTGANNNNNNNN
>OO408538.1 Sequence 5820 from patent US 11400144
ACACATTTTTTAA
>OO408402.1 Sequence 5678 from patent US 11400144
TATCGGTGATAAC
>OO408392.1 Sequence 5668 from patent US 11400144
AAAATAAAAATTG
>OO408390.1 Sequence 5666 from patent US 11400144
AAGAGGTGAGCAA
>OO408389.1 Sequence 5665 from patent US 11400144
TTAAAAAACTATT
>OO408377.1 Sequence 5653 from patent US 11400144
AAAAGGATTTAGT
>OO408373.1 Sequence 5649 from patent US 11400144
AATAAATAAAGGA
>OO408313.1 Sequence 5587 from patent US 11400144
TAATATCAAACTC
>OO407886.1 Sequence 5135 from patent US 11400144
ATTAAAAAAAAAG
>OO407685.1 Sequence 4926 from patent US 11400144
TTTAAAAATAGAT
>OO407650.1 Sequence 4887 from patent US 11400144
ATAACTCCTCCTT
>OO407414.1 Sequence 4645 from patent US 11400144
ATAAACACTTCCT
>OO407342.1 Sequence 4569 from patent US 11400144
AAAAAACATCCCC
>OO407329.1 Sequence 4555 from patent US 11400144
ATAATCACATATC
>OO407321.1 Sequence 4547 from patent US 11400144
AAGTCAGTTAATA
>OO407244.1 Sequence 4466 from patent US 11400144
ATTTATTCTATCC
>OO407001.1 Sequence 4218 from patent US 11400144
ATTGGTTAGATAT
>OO406957.1 Sequence 4173 from patent US 11400144
GTATGGTGATTAA
>OO406904.1 Sequence 4119 from patent US 11400144
AGTAAAGGATCTG
>OO406781.1 Sequence 3987 from patent US 11400144
CGGATTTTTTAAA
>OO406717.1 Sequence 3920 from patent US 11400144
TTAAATAACCTTC
>OO406628.1 Sequence 3825 from patent US 11400144
AAGGTAGAATATT
>OO406517.1 Sequence 3710 from patent US 11400144
TTTTTTTATTTTT
>OO406407.1 Sequence 3596 from patent US 11400144
AGCTCGTTCCGCT
>OO406399.1 Sequence 3586 from patent US 11400144
TTTGGTGATATAT
>OO406340.1 Sequence 3524 from patent US 11400144
TTTTTAATTACGG
>OO406270.1 Sequence 3445 from patent US 11400144
TTTCTTTTTTTTC
>OO406235.1 Sequence 3405 from patent US 11400144
ATGATTTTTGAAA
>OO406136.1 Sequence 3301 from patent US 11400144
TTTAATTTTAAGT
>OO405957.1 Sequence 3115 from patent US 11400144
TTAATAAAAAATA
>OO405457.1 Sequence 2615 from patent US 11400144
GGATTTTTAATCC
>OO405427.1 Sequence 2585 from patent US 11400144
CTCCTTAAAGGAG
>OO405398.1 Sequence 2556 from patent US 11400144
GTTAAAATTTAAC
>OO405372.1 Sequence 2530 from patent US 11400144
GATTAAAATAATC
>OO405357.1 Sequence 2515 from patent US 11400144
GAGATTTAATCTC
>OO405276.1 Sequence 2434 from patent US 11400144
GTATTTTAGATAC
>OO405257.1 Sequence 2415 from patent US 11400144
TGCATTTAATGCA
>OO405256.1 Sequence 2414 from patent US 11400144
TGCATTTAATGCA
>OO404813.1 Sequence 1971 from patent US 11400144
TTAGTTTAACTAA
>OO404774.1 Sequence 1932 from patent US 11400144
GCTACATTGTAGC
>OO404751.1 Sequence 1909 from patent US 11400144
CAGAACTCTTCTG
>OO404747.1 Sequence 1905 from patent US 11400144
TTATTATAAATAA
>OO404571.1 Sequence 1729 from patent US 11400144
GTAAGCAACTTAC
>OO404561.1 Sequence 1719 from patent US 11400144
GATGATTTTCATC
>OO402676.1 Sequence 41 from patent US 11400110
GTTTTTGTACTCT
>OO402671.1 Sequence 29 from patent US 11400110
AAAATCATTTGAG
>OO402670.1 Sequence 28 from patent US 11400110
AAATTCATTTGAG
>OO402617.1 Sequence 11 from patent US 11400075
CAGAGCAAGGACG
>OO259163.1 Sequence 3 from patent US 11352620
NNNNNNNGAAGAG
>OO259038.1 Sequence 33 from patent US 11352611
CAACGGACCTCTG
>OO256830.1 Sequence 32 from patent US 11351273
AAAGTCTTTCGCA
>OO255918.1 Sequence 477 from patent US 11345969
ATGGCTTTATAAT
>OO255917.1 Sequence 476 from patent US 11345969
ATGGCCCTATCAT
>OO255202.1 Sequence 17 from patent US 11345954
ATGTGCCAATCCC
>OO255200.1 Sequence 15 from patent US 11345954
TTGTGCATTTACC
>OO253049.1 Sequence 16 from patent US 11345917
ATCGAGGTCCGCG
>OO252787.1 Sequence 23 from patent US 11345914
TGAATACCAATGC
>OO252786.1 Sequence 22 from patent US 11345914
GCATTGGTATTCA
>OO240577.1 Sequence 5 from patent US 11344633
TGGTGGTGGTGGT
>OO240454.1 Sequence 295 from patent US 11344609
TTGACCAATAGCC
>OO240185.1 Sequence 16 from patent US 11344589
ACCGGTCGCCACC
>OO240090.1 Sequence 9 from patent US 11344524
AGGTCAAAGGACA
>OO235282.1 Sequence 6 from patent US 11339430
GTCGTACGGCTAA
>OO230919.1 Sequence 146 from patent US 11339392
ACCAAAAGAATTC
>OO230862.1 Sequence 89 from patent US 11339392
AGCCAGACAGCGA
>OO230840.1 Sequence 65 from patent US 11339392
AGCCAGACAGCGA
>OO230245.1 Sequence 80 from patent US 11339385
WATCAANNNNTTR
>OO230181.1 Sequence 2 from patent US 11339385
WATCAANNNNTTR
>OO228876.1 Sequence 218 from patent US 11337388
CGGACTCAAGCAC
>OO228790.1 Sequence 132 from patent US 11337388
CGGGAGTGACCTC
>OO228783.1 Sequence 125 from patent US 11337388
CGTCAAAATTTGC
>OO228779.1 Sequence 121 from patent US 11337388
CGCGACCCTCTCG
>OO228777.1 Sequence 119 from patent US 11337388
CTGGAGGCAAATC
>OO228773.1 Sequence 115 from patent US 11337388
AAGGGCCACTCAC
>OO228763.1 Sequence 105 from patent US 11337388
CGGGACTGACCTC
>OO228752.1 Sequence 94 from patent US 11337388
CGCGACCTTCTCG
>OO228750.1 Sequence 92 from patent US 11337388
CTGGACGCAAATC
>OO228657.1 Sequence 44623 from patent US 11332793
CCNCCNTNNCCNC
>OO183968.1 Sequence 148 from patent US 11332798
CCAGCACTGCCAT
>OO183884.1 Sequence 64 from patent US 11332798
CATTGACACAATG
>OO183254.1 Sequence 2 from patent US 11332778
CCATCTCATCCCT
>OO182446.1 Sequence 54 from patent US 11332760
TTTTTTTCTTTTT
>OO173305.1 Sequence 4 from patent US 11332737
TGCATGGATTACG
>OO173302.1 Sequence 1 from patent US 11332737
NACNTNGANAGTN
>OO170672.1 Sequence 1 from patent US 11332489
TAGGGTTAGACAA
>OO162961.1 Sequence 82 from patent US 11326165
TGCTAGCTGAGGA
>OO162947.1 Sequence 68 from patent US 11326165
TAGCAGGTAAGCA
>OO162929.1 Sequence 50 from patent US 11326165
GAGCAGGTAAGCT
>OO162635.1 Sequence 62 from patent US 11326161
AAGCGCGTACNNN
>OO162630.1 Sequence 57 from patent US 11326161
AAGCGCGTACNNN
>OO161869.1 Sequence 11 from patent US 11325957
GTTAATNATTAAC
>OO160970.1 Sequence 331 from patent US 11325948
GCCGCCACCANGN
>OO160969.1 Sequence 330 from patent US 11325948
GCCGCCGCCANGN
>OO159163.1 Sequence 17 from patent US 11324178
CATTGCAATTCCA
>OO398459.1 Sequence 5 from patent US 11396654
CTGTGGAAGTCTA
>OO350461.1 Sequence 25 from patent US 11390914
AAAAAAAAAAAAA
>OO350347.1 Sequence 24 from patent US 11390909
ATTTTGATGGTAT
>OO350295.1 Sequence 23 from patent US 11390908
TAGGGTTAGGGTT
>OO350267.1 Sequence 6 from patent US 11390905
GATCGGAAGAGCT
>OO350263.1 Sequence 2 from patent US 11390905
CTCCTGGCGGTTT
>OO345479.1 Sequence 43 from patent US 11390643
TGGWCATGTGGCT
>OO345443.1 Sequence 7 from patent US 11390643
CCAAGCACGATGT
>OO341805.1 Sequence 29 from patent US 11384396
CTGGTCTCAGAGT
>OO341313.1 Sequence 19 from patent US 11384383
CTGATGATGTTAA
>OO340471.1 Sequence 409 from patent US 11384361
GGAGCAATTCAAC
>OO340469.1 Sequence 407 from patent US 11384361
AACACACAGAGAA
>OO340464.1 Sequence 402 from patent US 11384361
TTTCCATACACTG
>OO340463.1 Sequence 401 from patent US 11384361
CACAGAGAATGGT
>OO339567.1 Sequence 72 from patent US 11384355
TATGGCTGTGCTG
>OO339563.1 Sequence 68 from patent US 11384355
TATTTACTGGAAC
>OO339560.1 Sequence 65 from patent US 11384355
TATATATCATCAC
>OO339531.1 Sequence 33 from patent US 11384355
TATGGCTGTGCTG
>OO339527.1 Sequence 29 from patent US 11384355
TATTTACTGGAAC
>OO339524.1 Sequence 26 from patent US 11384355
TATATATCATCAC
>OO339204.1 Sequence 20 from patent US 11384346
TTTTTTTTTTTTT
>OO338782.1 Sequence 939 from patent US 11384344
GGTGGGTTGAAAC
>OO336060.1 Sequence 11 from patent US 11382893
CAGAGCAAGGACG
>OO334383.1 Sequence 1923 from patent US 11377695
TTCCTTGGTGCCT
>OO334323.1 Sequence 1863 from patent US 11377695
TTCCTTGGTGCCT
>OO334221.1 Sequence 1761 from patent US 11377695
AGCCGAATCCATC
>OO334075.1 Sequence 1615 from patent US 11377695
ACTCCTTTGAAAC
>OO334016.1 Sequence 1556 from patent US 11377695
TTAAAATAAAATA
>OO333901.1 Sequence 1441 from patent US 11377695
ATATATATTTTTT
>OO332147.1 Sequence 57 from patent US 11377688
CANNCAACNGNGC
>OO332141.1 Sequence 51 from patent US 11377688
GGGGAAGNNGGNG
>OO332062.1 Sequence 21 from patent US 11377682
CAATTGTGACTTT
>OO332060.1 Sequence 19 from patent US 11377682
CACCAGCCTCCCA
>OO332037.1 Sequence 20 from patent US 11377681
GCAATATTTTTCT
>OO332036.1 Sequence 19 from patent US 11377681
GCAAGGTTTTTCT
>OO332035.1 Sequence 18 from patent US 11377681
GCAAGATTTTTCT
>OO303705.1 Sequence 373 from patent US 11371101
CCCAGGTGGTCCA
>OO303702.1 Sequence 370 from patent US 11371101
GAGGTCCTGAGGC
>OO303701.1 Sequence 369 from patent US 11371101
GGTTCTCTGCCTG
>OO303581.1 Sequence 249 from patent US 11371101
GTCCACAACGGTT
>OO303542.1 Sequence 210 from patent US 11371101
AACAGCCACAACG
>OO303524.1 Sequence 192 from patent US 11371101
CCCAGGTGGTCCA
>OO303497.1 Sequence 165 from patent US 11371101
GGTTCTCTGCCTG
>OO303482.1 Sequence 150 from patent US 11371101
GAGGTCCTGAGGC
>OO303392.1 Sequence 60 from patent US 11371101
CTGTCCATCTCCT
>OO303365.1 Sequence 33 from patent US 11371101
CAGACTCCAGCGG
>OO303353.1 Sequence 21 from patent US 11371101
CTGCCGCAAATTC
>OO303116.1 Sequence 91 from patent US 11371084
GTAAATAAATAAA
>OO303113.1 Sequence 88 from patent US 11371084
CTGTGTGTGTGTG
>OO303035.1 Sequence 10 from patent US 11371084
TGATAGATAGATA
>OO302230.1 Sequence 52 from patent US 11371079
ACCAGCCAGCTGA
>OO302220.1 Sequence 42 from patent US 11371079
ACCAGCCAGCTGA
>OO302206.1 Sequence 28 from patent US 11371079
ACCAGCCAGCTGA
>OO302201.1 Sequence 23 from patent US 11371079
AAGGACGCGATCA
>OO302200.1 Sequence 22 from patent US 11371079
ACCAGCCAGCTGA
>OO302195.1 Sequence 17 from patent US 11371079
AAGGACGCGATCA
>OO302191.1 Sequence 13 from patent US 11371079
ACCAGCCAGCTGA
>OO302179.1 Sequence 1 from patent US 11371079
TGCATCCAGTGGT
>OO301608.1 Sequence 26 from patent US 11371051
TTACTGCATTCGA
>OO301606.1 Sequence 24 from patent US 11371051
TTACTGCATTCGA
>OO301603.1 Sequence 21 from patent US 11371051
TTACTGCATTCGA
>OO301594.1 Sequence 12 from patent US 11371051
TTACTGCATTCCA
>OO301565.1 Sequence 218 from patent US 11371050
GTTCGATGCACTG
>OO280539.1 Sequence 56 from patent US 11359252
GTAGAAACCTCGC
>OO278816.1 Sequence 3 from patent US 11359232
GGCTGCGCAGTAT
>OO278806.1 Sequence 52 from patent US 11359230
ACCAGCCAGCTGA
>OO278796.1 Sequence 42 from patent US 11359230
ACCAGCCAGCTGA
>OO278782.1 Sequence 28 from patent US 11359230
ACCAGCCAGCTGA
>OO278777.1 Sequence 23 from patent US 11359230
AAGGACGCGATCA
>OO278776.1 Sequence 22 from patent US 11359230
ACCAGCCAGCTGA
>OO278771.1 Sequence 17 from patent US 11359230
AAGGACGCGATCA
>OO278767.1 Sequence 13 from patent US 11359230
ACCAGCCAGCTGA
>OO278755.1 Sequence 1 from patent US 11359230
TGCATCCAGTGGT
>OO269357.1 Sequence 20 from patent US 11357790
TCGCCATGCTGCT
>OO269253.1 Sequence 88 from patent US 11357217
CCACTGGCATCCC
>OO269157.1 Sequence 30 from patent US 11357189
CGAGCCACCACCG
>OO269156.1 Sequence 29 from patent US 11357189
TGAGCCACCACCG
>OO269154.1 Sequence 27 from patent US 11357189
GAGGGTCGTCGCT
>OO159088.1 Sequence 830 from patent US 11320421
CGAACCACTGAAC
>OO159087.1 Sequence 829 from patent US 11320421
GCGTAAAGAGAGG
>OO159079.1 Sequence 821 from patent US 11320421
CGAAGTGCACACG
>OO149616.1 Sequence 36 from patent US 11319577
AATACATCATCAT
>OO149605.1 Sequence 25 from patent US 11319577
AATACATCATCAT
>OO149597.1 Sequence 17 from patent US 11319577
AATACATCATCAT
>OO148874.1 Sequence 107 from patent US 11319549
CTAATTATTGTTT
>OO143125.1 Sequence 733 from patent US 11315659
TTGCCCACAGGGC
>OO142112.1 Sequence 44623 from patent US 11312996
CCNCCNTNNCCNC
>OO095269.1 Sequence 102 from patent US 11312965
TCGAACGTTCGAG
>OO079878.1 Sequence 5 from patent US 11312945
GTACCAAATAATT
>OO078011.1 Sequence 56 from patent US 11312759
GGCCTCTGCGGCC
>OO078010.1 Sequence 55 from patent US 11312759
GGCCCAGCCGGCC
>OO076895.1 Sequence 9 from patent US 11311616
GGCGCGCCGCACC
>OO076516.1 Sequence 2 from patent US 11311577
ATTTATTTATTTA
>OO076436.1 Sequence 182 from patent US 11311574
ACGTAGACTGAGG
>OO076434.1 Sequence 180 from patent US 11311574
GAAGTCTGCCGTT
>OO076433.1 Sequence 179 from patent US 11311574
GAAGTCTGCCGTT
>OO076403.1 Sequence 119 from patent US 11311574
AACACGAAACGTG
>OO076373.1 Sequence 48 from patent US 11311574
TAGAGGAGAAAGG
>pdb|7Y2P|B Chain B, Crystal structure of CUG repeat RNA duplex containing A-U base pair and U-U mismatches
NTCTGCAGCTGAA
>pdb|7Y2P|A Chain A, Crystal structure of CUG repeat RNA duplex containing A-U base pair and U-U mismatches
NTCTGCTGCTGAA
>pdb|7Y2B|S Chain S, Crystal structure of CUG repeat RNA duplex containing U-U mismatches
NTCTGCTGCTGAA
>pdb|8E2Q|H Chain H, Crystal structure of TadAC-1.17 in a complex with ssDNA
GCTCGGCTNCGGA
>pdb|8E2Q|G Chain G, Crystal structure of TadAC-1.17 in a complex with ssDNA
GCTCGGCTNCGGA
>pdb|8E2Q|F Chain F, Crystal structure of TadAC-1.17 in a complex with ssDNA
NCTCGGCTNCGGA
>pdb|8E2Q|E Chain E, Crystal structure of TadAC-1.17 in a complex with ssDNA
NCTCGGCTNCGGA
>pdb|8E2P|H Chain H, Crystal structure of TadA*8.20 in a complex with ssDNA
GCTCGGCTNCGGA
>pdb|8E2P|G Chain G, Crystal structure of TadA*8.20 in a complex with ssDNA
GCTCGGCTNCGGA
>pdb|8E2P|F Chain F, Crystal structure of TadA*8.20 in a complex with ssDNA
GCTCGGCTNCGGA
>pdb|8E2P|E Chain E, Crystal structure of TadA*8.20 in a complex with ssDNA
NCTCGGCTNCGGA
>PA574774.1 WO 2023022055-A/2: Modified polynucleotide
GCATTGGTATTCA
>PA573738.1 JP 2023015421-A/63: Enhancer
GGGCTGGGCGCTG
>pdb|8FTJ|F Chain F, Crystal structure of human NEIL1 (P2G (242K) C(delta)100) glycosylase bound to DNA duplex containing urea
TAGACATGGACGG
>pdb|8FTJ|D Chain D, Crystal structure of human NEIL1 (P2G (242K) C(delta)100) glycosylase bound to DNA duplex containing urea
CGTCCANGTCTAC
>pdb|7MXW|A Chain A, Crystal structure of human exonuclease 1 Exo1 (WT) in complex with 5' flap DNA (uf1)
CGCTAGTCGACAT
>pdb|7MXV|A Chain A, Crystal structure of human exonuclease 1 Exo1 (WT) in complex with 5' recessed-end DNA (ur)
CGCTAGTCGACAT
>pdb|7MXU|A Chain A, Crystal structure of human exonuclease 1 Exo1 (WT) in complex with 5' flap DNA (cf2)
CGCTAGTCGACAT
>pdb|7MXT|A Chain A, Crystal structure of human exonuclease 1 Exo1 (WT) in complex with 5' recessed-end DNA (cmr)
CGCTAGTCGACAT
>pdb|7MXS|A Chain A, Crystal structure of human exonuclease 1 Exo1 (WT) in complex with 5' recessed-end DNA (cr)
CGCTAGTCGACAT
>pdb|7MXR|A Chain A, Crystal structure of human exonuclease 1 Exo1 (WT) in complex with 5' recessed-end DNA (r-2)
CGCTAGTCGACAT
>pdb|7MXQ|A Chain A, Crystal structure of human exonuclease 1 Exo1 (WT) in complex with 5' recessed-end DNA (r-1)
CGCTAGTCGACAT
>pdb|8H9H|B Chain B, Crystal structure of ZBTB7A in complex with GACCC-containing sequence
NATCTGGGTCCTT
>pdb|8H9H|A Chain A, Crystal structure of ZBTB7A in complex with GACCC-containing sequence
TAAGGACCCAGAT
>pdb|7URK|A Chain A, Self-assembling DNA tensegrity triangle motif with intercalating internal Cy3 modification
GAGCANGCCTGTA
>OO075045.1 Sequence 10 from patent US 11306361
GGCCGCGCCATGG
>OO074493.1 Sequence 58 from patent US 11306355
GTCGACCGGATCN
>OO074492.1 Sequence 57 from patent US 11306355
GTCGACCGGATCN
>OO074491.1 Sequence 56 from patent US 11306355
GTCGACCGGATCN
>OO074413.1 Sequence 28 from patent US 11306350
TCCTGCGAGACGG
>OO074412.1 Sequence 27 from patent US 11306350
TGCGAGCAGTGGC
>OO067067.1 Sequence 67 from patent US 11305282
CGAGTTTCCTTGG
>OO064845.1 Sequence 81 from patent US 11300509
AAAAAAAAAAAAA
>OO064801.1 Sequence 11 from patent US 11299789
GAGACGATACGAT
>OO064548.1 Sequence 4 from patent US 11299770
ATTGTTATTGTTA
>OO064546.1 Sequence 2 from patent US 11299770
ATTTATTTATTTA
>OO064545.1 Sequence 1 from patent US 11299770
NAAANAAANAAAN
>OO064532.1 Sequence 3 from patent US 11299769
CGAACTATACAAC
>OO063394.1 Sequence 81 from patent US 11299739
ATTTTTAAAATTG
>OO063393.1 Sequence 80 from patent US 11299739
CAATTTTAAAAAT
>OO063392.1 Sequence 79 from patent US 11299739
ATTTTTAAAATTA
>OO063391.1 Sequence 78 from patent US 11299739
TAATTTTAAAAAT
>OO063185.1 Sequence 85 from patent US 11299736
GCATTGGTATTCA
>OO063079.1 Sequence 16 from patent US 11299735
CNCACCNGGAGCA
>OO063072.1 Sequence 6 from patent US 11299735
NCACCNGGAGCAN
>OO062507.1 Sequence 25 from patent US 11299719
TTCNNTANCGTTT
>OO062474.1 Sequence 9 from patent US 11299718
AACGACGGCCAGT
>OO061864.1 Sequence 16 from patent US 11299511
GTTAGGGTTAGAC
>OO061860.1 Sequence 12 from patent US 11299511
ACGGTGGAAGGCG
>OO061859.1 Sequence 11 from patent US 11299511
CGGTGGAAGGCGG
>OO061857.1 Sequence 9 from patent US 11299511
GTGGAAGGCGGCA
>OO061856.1 Sequence 8 from patent US 11299511
GGAAGGCGGCAGG
>OO061853.1 Sequence 5 from patent US 11299511
CAGTTAGGGTTAG
>OO061851.1 Sequence 3 from patent US 11299511
TAGGGTTAGACAA
>OO003261.1 Sequence 16 from patent US 11292830
GGCCTCTGCGGCC
>OO003260.1 Sequence 15 from patent US 11292830
GGCCCAGCCGGCC
>MY998621.1 Sequence 9 from patent US 11286532
GTGAAGCTTCGAT
>MY998617.1 Sequence 5 from patent US 11286532
GGTCANNNTGACC
>MY998346.1 Sequence 44623 from patent US 11286530
CCNCCNTNNCCNC
>MY946490.1 Sequence 36 from patent US 11286482
GCCAGGTAAGTAT
>MY944934.1 Sequence 2 from patent US 11281856
TTTAAATCTGTGG
>MY944814.1 Sequence 27 from patent US 11279982
CATGGGTGCATCG
>MY944795.1 Sequence 4 from patent US 11279982
ACCACATAATTAC
>MY943518.1 Sequence 1023 from patent US 11279934
GCACCTTTCTAGA
>MY943516.1 Sequence 1021 from patent US 11279934
GCACCTTTCTAGA
>MY943512.1 Sequence 1017 from patent US 11279934
CCTCATGTTTATA
>MY943510.1 Sequence 1015 from patent US 11279934
AAATACCTCATGA
>MY943508.1 Sequence 1013 from patent US 11279934
GAAATACCTCATA
>MY943506.1 Sequence 1011 from patent US 11279934
ACTTTGAAATACA
>MY943504.1 Sequence 1009 from patent US 11279934
TGCTGCATCTTAA
>MY943502.1 Sequence 1007 from patent US 11279934
AGTGCTGCATCTA
>MY943500.1 Sequence 1005 from patent US 11279934
TAGTGCTGCATCA
>MY943498.1 Sequence 1003 from patent US 11279934
TTAGTGCTGCATA
>MY943496.1 Sequence 1001 from patent US 11279934
TTCTGTGTTTAAA
>MY943494.1 Sequence 999 from patent US 11279934
GTTCTGTGTTTAA
>MY943492.1 Sequence 997 from patent US 11279934
AGTTCTGTGTTTA
>MY943490.1 Sequence 995 from patent US 11279934
GGTGCATAGAACA
>MY943488.1 Sequence 993 from patent US 11279934
TTTGGTGCATAGA
>MY943486.1 Sequence 991 from patent US 11279934
GTTTGGTGCATAA
>MY943484.1 Sequence 989 from patent US 11279934
TTCATGTTTGGTA
>MY943482.1 Sequence 987 from patent US 11279934
GTTCATGTTTGGA
>MY943480.1 Sequence 985 from patent US 11279934
TGTTCATGTTTGA
>MY943478.1 Sequence 983 from patent US 11279934
AGCCTGTTTCTTA
>MY943476.1 Sequence 981 from patent US 11279934
CCTAGCCTGTTTA
>MY943474.1 Sequence 979 from patent US 11279934
TCCTAGCCTGTTA
>MY943472.1 Sequence 977 from patent US 11279934
GTTTTGAGTAGAA
>MY943470.1 Sequence 975 from patent US 11279934
AGTTTTGAGTAGA
>MY943468.1 Sequence 973 from patent US 11279934
AAGTTTTGAGTAA
>MY943466.1 Sequence 971 from patent US 11279934
TGAAAGTTTTGAA
>MY943464.1 Sequence 969 from patent US 11279934
GAGTTGTGAAAGA
>MY943462.1 Sequence 967 from patent US 11279934
AAAATGAGTTGTA
>MY943460.1 Sequence 965 from patent US 11279934
GAAAATGAGTTGA
>MY943458.1 Sequence 963 from patent US 11279934
TGAAAATGAGTTA
>MY943456.1 Sequence 961 from patent US 11279934
TACATAACTAAAA
>MY943454.1 Sequence 959 from patent US 11279934
GATACATAACTAA
>MY943452.1 Sequence 957 from patent US 11279934
CTGATACATAACA
>MY943450.1 Sequence 955 from patent US 11279934
GCTGATACATAAA
>MY943448.1 Sequence 953 from patent US 11279934
ACGCTGATACATA
>MY943446.1 Sequence 951 from patent US 11279934
GACGCTGATACAA
>MY943444.1 Sequence 949 from patent US 11279934
TGACGCTGATACA
>MY943442.1 Sequence 947 from patent US 11279934
AGTATGACGCTGA
>MY943440.1 Sequence 945 from patent US 11279934
TTTAGTATGACGA
>MY943438.1 Sequence 943 from patent US 11279934
CTTTAGTATGACA
>MY943436.1 Sequence 941 from patent US 11279934
TACTTTAGTATGA
>MY943434.1 Sequence 939 from patent US 11279934
TATACTTTAGTAA
>MY943432.1 Sequence 937 from patent US 11279934
GTATACTTTAGTA
>MY943430.1 Sequence 935 from patent US 11279934
TAATTCTTACACA
>MY943428.1 Sequence 933 from patent US 11279934
CTAATTCTTACAA
>MY943426.1 Sequence 931 from patent US 11279934
TGTACTGTACTAA
>MY943424.1 Sequence 929 from patent US 11279934
TATGTACTGTACA
>MY943422.1 Sequence 927 from patent US 11279934
TGTTTTGTATACA
>MY943420.1 Sequence 925 from patent US 11279934
AGCATGTTTTGTA
>MY943418.1 Sequence 923 from patent US 11279934
GGAGCATGTTTTA
>MY943416.1 Sequence 921 from patent US 11279934
AGGAGCATGTTTA
>MY943414.1 Sequence 919 from patent US 11279934
GAGGAGCATGTTA
>MY943412.1 Sequence 917 from patent US 11279934
TGAGGAGCATGTA
>MY943410.1 Sequence 915 from patent US 11279934
TTGAGGAGCATGA
>MY943408.1 Sequence 913 from patent US 11279934
TTTGAGGAGCATA
>MY943406.1 Sequence 911 from patent US 11279934
GTTTGAGGAGCAA
>MY943404.1 Sequence 909 from patent US 11279934
ATGTTTGAGGAGA
>MY943402.1 Sequence 907 from patent US 11279934
AATGTTTGAGGAA
>MY943400.1 Sequence 905 from patent US 11279934
CAATGTTTGAGGA
>MY943398.1 Sequence 903 from patent US 11279934
ACCTAAGTACTGA
>MY943396.1 Sequence 901 from patent US 11279934
ATACCTAAGTACA
>MY943394.1 Sequence 899 from patent US 11279934
CATACCTAAGTAA
>MY943392.1 Sequence 897 from patent US 11279934
TTCATACCTAAGA
>MY943390.1 Sequence 895 from patent US 11279934
GAAGTTCATACCA
>MY943388.1 Sequence 893 from patent US 11279934
GGAAGTTCATACA
>MY943386.1 Sequence 891 from patent US 11279934
TGGAAGTTCATAA
>MY943384.1 Sequence 889 from patent US 11279934
CTGGAAGTTCATA
>MY943382.1 Sequence 887 from patent US 11279934
GACTGGAAGTTCA
>MY943380.1 Sequence 885 from patent US 11279934
TAGACTGGAAGTA
>MY943378.1 Sequence 883 from patent US 11279934
CCAGTATTAGACA
>MY943376.1 Sequence 881 from patent US 11279934
GCCAGTATTAGAA
>MY943374.1 Sequence 879 from patent US 11279934
GGCCAGTATTAGA
>MY943372.1 Sequence 877 from patent US 11279934
AGGTGGCTTTTGA
>MY943370.1 Sequence 875 from patent US 11279934
GAGGTGGCTTTTA
>MY943368.1 Sequence 873 from patent US 11279934
AGAGGTGGCTTTA
>MY943366.1 Sequence 871 from patent US 11279934
GAGAGGTGGCTTA
>MY943364.1 Sequence 869 from patent US 11279934
GTATACATCCTGA
>MY943362.1 Sequence 867 from patent US 11279934
TTTTGTATACATA
>MY943360.1 Sequence 865 from patent US 11279934
TCCGCCTTTTGTA
>MY943358.1 Sequence 863 from patent US 11279934
ATACCATTGACAA
>MY943356.1 Sequence 861 from patent US 11279934
AATACCATTGACA
>MY943354.1 Sequence 859 from patent US 11279934
AAATACCATTGAA
>MY943352.1 Sequence 857 from patent US 11279934
TGCTTAAGTTCCA
>MY943350.1 Sequence 855 from patent US 11279934
GTGCTTAAGTTCA
>MY943348.1 Sequence 853 from patent US 11279934
CTTTCAAATCGGA
>MY943346.1 Sequence 851 from patent US 11279934
ACTTTCAAATCGA
>MY943344.1 Sequence 849 from patent US 11279934
TACTTTCAAATCA
>MY943342.1 Sequence 847 from patent US 11279934
TTACTTTCAAATA
>MY943340.1 Sequence 845 from patent US 11279934
AAGAATGTTGGTA
>MY943338.1 Sequence 843 from patent US 11279934
TAAGAATGTTGGA
>MY943336.1 Sequence 841 from patent US 11279934
TTAAGAATGTTGA
>MY943334.1 Sequence 839 from patent US 11279934
ACATTAAGAATGA
>MY943332.1 Sequence 837 from patent US 11279934
GTTGACATTAAGA
>MY943330.1 Sequence 835 from patent US 11279934
TTGTGTTGACATA
>MY943328.1 Sequence 833 from patent US 11279934
ATTGTGTTGACAA
>MY943326.1 Sequence 831 from patent US 11279934
GCACATTTTGATA
>MY943324.1 Sequence 829 from patent US 11279934
TGCACATTTTGAA
>MY943322.1 Sequence 827 from patent US 11279934
ACTTTGCACATTA
>MY943320.1 Sequence 825 from patent US 11279934
CCACTTTGCACAA
>MY943318.1 Sequence 823 from patent US 11279934
ACACGCTCGGACA
>MY943316.1 Sequence 821 from patent US 11279934
TGAACACGCTCGA
>MY943314.1 Sequence 819 from patent US 11279934
TTGAACACGCTCA
>MY943312.1 Sequence 817 from patent US 11279934
ATTGAACACGCTA
>MY943310.1 Sequence 815 from patent US 11279934
AATTGAACACGCA
>MY943308.1 Sequence 813 from patent US 11279934
GAAAATTGAACAA
>MY943306.1 Sequence 811 from patent US 11279934
GCTAAAGAAAATA
>MY943304.1 Sequence 809 from patent US 11279934
TGCTAAAGAAAAA
>MY943302.1 Sequence 807 from patent US 11279934
GTTGCTAAAGAAA
>MY943300.1 Sequence 805 from patent US 11279934
GCAGCAGTTGCTA
>MY943298.1 Sequence 803 from patent US 11279934
TTGCAGGCAAGAA
>MY943296.1 Sequence 801 from patent US 11279934
ATTGCAGGCAAGA
>MY943294.1 Sequence 799 from patent US 11279934
CACTGAGTATGTA
>MY943292.1 Sequence 797 from patent US 11279934
GCCACTGAGTATG
>MY943290.1 Sequence 795 from patent US 11279934
TTTGAAAAAGGCA
>MY943288.1 Sequence 793 from patent US 11279934
ATTTTGAAAAAGA
>MY943286.1 Sequence 791 from patent US 11279934
CATTTTGAAAAAA
>MY943284.1 Sequence 789 from patent US 11279934
TGGTCATTTTGAA
>MY943282.1 Sequence 787 from patent US 11279934
AAAGAATGAGAAA
>MY943280.1 Sequence 785 from patent US 11279934
GTAAAGAATGAGA
>MY943278.1 Sequence 783 from patent US 11279934
TGGTAAAGAATGA
>MY943276.1 Sequence 781 from patent US 11279934
TTGGTAAAGAATA
>MY943274.1 Sequence 779 from patent US 11279934
TAAGAGCTTGAGA
>MY943272.1 Sequence 777 from patent US 11279934
CTAAGAGCTTGAA
>MY943270.1 Sequence 775 from patent US 11279934
GCTAAGAGCTTGA
>MY943268.1 Sequence 773 from patent US 11279934
CACATTCACCATA
>MY943266.1 Sequence 771 from patent US 11279934
ATCGACGTGGTCA
>MY943264.1 Sequence 769 from patent US 11279934
TTCAGATGATGAA
>MY943262.1 Sequence 767 from patent US 11279934
ATTCAGATGATGA
>MY943260.1 Sequence 765 from patent US 11279934
AAGTTTGAGCTGA
>MY943258.1 Sequence 763 from patent US 11279934
AGAAGTTTGAGCA
>MY943256.1 Sequence 761 from patent US 11279934
TGGAAGAAGTTTA
>MY943254.1 Sequence 759 from patent US 11279934
ACTTCTACTTCGA
>MY943252.1 Sequence 757 from patent US 11279934
AGATGACTTCTAA
>MY943250.1 Sequence 755 from patent US 11279934
AAGATGACTTCTA
>MY943224.1 Sequence 729 from patent US 11279934
CAAATGATTGTGA
>MY943223.1 Sequence 728 from patent US 11279934
ATTCAAATGATTA
>MY943222.1 Sequence 727 from patent US 11279934
CAAAGAAGCTAAA
>MY943221.1 Sequence 726 from patent US 11279934
AAAATGGTTGCAA
>MY943220.1 Sequence 725 from patent US 11279934
ATAGCAGCCAAGA
>MY943219.1 Sequence 724 from patent US 11279934
TTATTTATAGCAA
>MY943218.1 Sequence 723 from patent US 11279934
AACTGGAAAACTA
>MY943217.1 Sequence 722 from patent US 11279934
ATGAAATGAATCA
>MY943216.1 Sequence 721 from patent US 11279934
TGCAATGAAATGA
>MY943215.1 Sequence 720 from patent US 11279934
TGACTATTGGAAA
>MY943214.1 Sequence 719 from patent US 11279934
AGCTGACTATTGA
>MY943213.1 Sequence 718 from patent US 11279934
TAGCTGACTATTA
>MY943212.1 Sequence 717 from patent US 11279934
TCCTTAGCTGACA
>MY943211.1 Sequence 716 from patent US 11279934
TGAAATTTCCTTA
>MY943210.1 Sequence 715 from patent US 11279934
AGTTGAATCTCTA
>MY943209.1 Sequence 714 from patent US 11279934
CAGTTTAGTGTAA
>MY943208.1 Sequence 713 from patent US 11279934
CAGGATTCAGTTA
>MY943207.1 Sequence 712 from patent US 11279934
ATCTAGAAGGAGA
>MY943206.1 Sequence 711 from patent US 11279934
GAAACCTTCATCA
>MY943205.1 Sequence 710 from patent US 11279934
ACAGGAAAATATA
>MY943204.1 Sequence 709 from patent US 11279934
ATATTATGACTAA
>MY943203.1 Sequence 708 from patent US 11279934
CAGTATATTATGA
>MY943202.1 Sequence 707 from patent US 11279934
CAACATGTCTGTA
>MY943201.1 Sequence 706 from patent US 11279934
ACCAACATGTCTA
>MY943200.1 Sequence 705 from patent US 11279934
GTGCAATACCAAA
>MY943198.1 Sequence 703 from patent US 11279934
TGCGGATCAAACA
>MY943184.1 Sequence 689 from patent US 11279934
AGAACAGTCCTTA
>MY943183.1 Sequence 688 from patent US 11279934
AGAACAGTCCTTA
>MY943182.1 Sequence 687 from patent US 11279934
AGAACAGTCCTTA
>MY943180.1 Sequence 685 from patent US 11279934
AGAACAGTCCTTA
>MY943176.1 Sequence 681 from patent US 11279934
CACTAGCTTATCA
>MY943174.1 Sequence 679 from patent US 11279934
TCACTAGCTTATA
>MY943172.1 Sequence 677 from patent US 11279934
ATCTTTTGCTCTA
>MY943170.1 Sequence 675 from patent US 11279934
TATCTTTTGCTCA
>MY943168.1 Sequence 673 from patent US 11279934
AACCACTAGTTCA
>MY943166.1 Sequence 671 from patent US 11279934
GAAACCACTAGTA
>MY943164.1 Sequence 669 from patent US 11279934
CAGAAAGACAGAA
>MY943162.1 Sequence 667 from patent US 11279934
TTGACTGCTGTGA
>MY943160.1 Sequence 665 from patent US 11279934
GGATTCGCCATTA
>MY943158.1 Sequence 663 from patent US 11279934
TGCGGATCAAACA
>MY943156.1 Sequence 661 from patent US 11279934
GATTATGCGGATA
>MY943154.1 Sequence 659 from patent US 11279934
TGCAGATTATGCA
>MY943152.1 Sequence 657 from patent US 11279934
CAGAACAGTCCTA
>MY943150.1 Sequence 655 from patent US 11279934
TGCTACTGTTTAA
>MY943148.1 Sequence 653 from patent US 11279934
ATTGGTGCTACTA
>MY943146.1 Sequence 651 from patent US 11279934
CTCTCTCCTTTTA
>MY943144.1 Sequence 649 from patent US 11279934
TCTCTCTCCTTTA
>MY943142.1 Sequence 647 from patent US 11279934
AATCTCTCTCCTA
>MY943140.1 Sequence 645 from patent US 11279934
AAATAAGGTTTCA
>MY943138.1 Sequence 643 from patent US 11279934
ACACTCAGCTCTA
>MY943136.1 Sequence 641 from patent US 11279934
GAAAAGAGAAAGA
>MY943134.1 Sequence 639 from patent US 11279934
AGAAAAGAGAAAA
>MY943132.1 Sequence 637 from patent US 11279934
GAGAAAAGAGAAA
>MY943130.1 Sequence 635 from patent US 11279934
TTGAAACCACTAA
>MY943128.1 Sequence 633 from patent US 11279934
TGTTATTGGTGTA
>MY943126.1 Sequence 631 from patent US 11279934
TTAATCCAGAAAA
>MY943124.1 Sequence 629 from patent US 11279934
GTCCTTAATCCAA
>MY943122.1 Sequence 627 from patent US 11279934
CAGTCCTTAATCA
>MY943120.1 Sequence 625 from patent US 11279934
GAACAGTCCTTAA
>MY943118.1 Sequence 623 from patent US 11279934
AGAACAGTCCTTA
>MY943116.1 Sequence 621 from patent US 11279934
GATGAGCTTCCTA
>MY943114.1 Sequence 619 from patent US 11279934
GTGACCAAAAGTA
>MY943112.1 Sequence 617 from patent US 11279934
GTGACCAAAAGTA
>MY943110.1 Sequence 615 from patent US 11279934
GCACCTTTCTAGA
>MY943108.1 Sequence 613 from patent US 11279934
GTGACCAAAAGTA
>MY943106.1 Sequence 611 from patent US 11279934
GTGACCAAAAGTA
>MY943104.1 Sequence 609 from patent US 11279934
GTGACCAAAAGTA
>MY943102.1 Sequence 607 from patent US 11279934
GTGACCAAAAGTA
>MY943100.1 Sequence 605 from patent US 11279934
GTGACCAAAAGTA
>MY943098.1 Sequence 603 from patent US 11279934
GTGACCAAAAGTA
>MY943096.1 Sequence 601 from patent US 11279934
GTGACCAAAAGTA
>MY943094.1 Sequence 599 from patent US 11279934
GTGACCAAAAGTA
>MY943092.1 Sequence 597 from patent US 11279934
GTGACCAAAAGTA
>MY943090.1 Sequence 595 from patent US 11279934
GCACCTTTCTAGA
>MY943088.1 Sequence 593 from patent US 11279934
GCACCTTTCTAGA
>MY943086.1 Sequence 591 from patent US 11279934
GCACCTTTCTAGA
>MY943084.1 Sequence 589 from patent US 11279934
GCACCTTTCTAGA
>MY943082.1 Sequence 587 from patent US 11279934
GCACCTTTCTAGA
>MY943080.1 Sequence 585 from patent US 11279934
CCTTTCTAGTTGA
>MY943078.1 Sequence 583 from patent US 11279934
CCTTTCTAGTTGA
>MY943076.1 Sequence 581 from patent US 11279934
CCTTTCTAGTTGA
>MY943050.1 Sequence 555 from patent US 11279934
GCACCTTTCTAGA
>MY943048.1 Sequence 553 from patent US 11279934
GCACCTTTCTAGA
>MY943046.1 Sequence 551 from patent US 11279934
GCACCTTTCTAGA
>MY943044.1 Sequence 549 from patent US 11279934
GCACCTTTCTAGA
>MY943042.1 Sequence 547 from patent US 11279934
GCACCTTTCTAGA
>MY943040.1 Sequence 545 from patent US 11279934
GCACCTTTCTAGA
>MY943038.1 Sequence 543 from patent US 11279934
GCACCTTTCTAGA
>MY943036.1 Sequence 541 from patent US 11279934
GCACCTTTCTAGA
>MY943034.1 Sequence 539 from patent US 11279934
GCACCTTTCTAGA
>MY943032.1 Sequence 537 from patent US 11279934
CCTTTCTAGTTGA
>MY943030.1 Sequence 535 from patent US 11279934
CCTTTCTAGTTGA
>MY943028.1 Sequence 533 from patent US 11279934
CCTTTCTAGTTGA
>MY943026.1 Sequence 531 from patent US 11279934
CCTTTCTAGTTGA
>MY943024.1 Sequence 529 from patent US 11279934
CCTTTCTAGTTGA
>MY943022.1 Sequence 527 from patent US 11279934
CCTTTCTAGTTGA
>MY943020.1 Sequence 525 from patent US 11279934
CCTTTCTAGTTGA
>MY943018.1 Sequence 523 from patent US 11279934
CCTTTCTAGTTGA
>MY943016.1 Sequence 521 from patent US 11279934
CCTTTCTAGTTGA
>MY943014.1 Sequence 519 from patent US 11279934
CCTTTCTAGTTGA
>MY943012.1 Sequence 517 from patent US 11279934
CCTTTCTAGTTGA
>MY943010.1 Sequence 515 from patent US 11279934
CCTTTCTAGTTGA
>MY943008.1 Sequence 513 from patent US 11279934
CCTTTCTAGTTGA
>MY942976.1 Sequence 481 from patent US 11279934
GTGACCAAAAGTA
>MY942974.1 Sequence 479 from patent US 11279934
GTGACCAAAAGTA
>MY942972.1 Sequence 477 from patent US 11279934
GTGACCAAAAGTA
>MY942970.1 Sequence 475 from patent US 11279934
GCACCTTTCTAGA
>MY942968.1 Sequence 473 from patent US 11279934
GCACCTTTCTAGA
>MY942966.1 Sequence 471 from patent US 11279934
GCACCTTTCTAGA
>MY942964.1 Sequence 469 from patent US 11279934
GCACCTTTCTAGA
>MY942962.1 Sequence 467 from patent US 11279934
GCACCTTTCTAGA
>MY942960.1 Sequence 465 from patent US 11279934
GCACCTTTCTAGA
>MY942958.1 Sequence 463 from patent US 11279934
GCACCTTTCTAGA
>MY942956.1 Sequence 461 from patent US 11279934
GCACCTTTCTAGA
>MY942954.1 Sequence 459 from patent US 11279934
GCACCTTTCTAGA
>MY942952.1 Sequence 457 from patent US 11279934
GCACCTTTCTAGA
>MY942950.1 Sequence 455 from patent US 11279934
GCACCTTTCTAGA
>MY942948.1 Sequence 453 from patent US 11279934
CCTTTCTAGTTGA
>MY942946.1 Sequence 451 from patent US 11279934
GCACCTTTCTAGA
>MY942944.1 Sequence 449 from patent US 11279934
GACCAAAAGTTAA
>MY942942.1 Sequence 447 from patent US 11279934
GTGACCAAAAGTA
>MY942938.1 Sequence 443 from patent US 11279934
TGTGACCAAAAGA
>MY942936.1 Sequence 441 from patent US 11279934
GTGTGACCAAAAA
>MY942932.1 Sequence 437 from patent US 11279934
AGTGTGACCAAAA
>MY942930.1 Sequence 435 from patent US 11279934
TGAGAGTGTGACA
>MY942928.1 Sequence 433 from patent US 11279934
TTGAGCTTTCTGA
>MY942924.1 Sequence 429 from patent US 11279934
TGCACCTTTCTAA
>MY942920.1 Sequence 425 from patent US 11279934
TGTTGAGAGTGTA
>MY942918.1 Sequence 423 from patent US 11279934
CAGTTTATTTGTA
>MY942914.1 Sequence 419 from patent US 11279934
ACAAGCCAGATTA
>MY942910.1 Sequence 415 from patent US 11279934
TTTGCCTGTAACA
>MY942908.1 Sequence 413 from patent US 11279934
CTGTCGATTAGAA
>MY942906.1 Sequence 411 from patent US 11279934
TTCTGATTCGAAA
>MY942904.1 Sequence 409 from patent US 11279934
CATTCTGATTCGA
>MY942902.1 Sequence 407 from patent US 11279934
TTGAGAAGGAAAA
>MY942900.1 Sequence 405 from patent US 11279934
AATTGAGAAGGAA
>MY942898.1 Sequence 403 from patent US 11279934
TGAAGTGTAATTA
>MY942894.1 Sequence 399 from patent US 11279934
GATAGCATCTTAA
>MY942890.1 Sequence 395 from patent US 11279934
TGAAGAATGTTAA
>MY942886.1 Sequence 391 from patent US 11279934
ACATTAACTCATA
>MY942884.1 Sequence 389 from patent US 11279934
GAAGCTGACCTGG
>MY942882.1 Sequence 387 from patent US 11279934
TATCAAGTTTGAG
>MY942880.1 Sequence 385 from patent US 11279934
CCGCAAGATCGGC
>MY942878.1 Sequence 383 from patent US 11279934
AGACACGTTTGGC
>MY942876.1 Sequence 381 from patent US 11279934
CTAAATTCTGTGG
>MY942874.1 Sequence 379 from patent US 11279934
GCTAAATTCTGTG
>MY942872.1 Sequence 377 from patent US 11279934
CTGTGACTTCGGC
>MY942870.1 Sequence 375 from patent US 11279934
CCTTGCGAAGCTG
>MY942868.1 Sequence 373 from patent US 11279934
TGCGAAGCTGACC
>MY942866.1 Sequence 371 from patent US 11279934
TACGGAGACATGG
>MY942864.1 Sequence 369 from patent US 11279934
CCTGTTCCAAGAC
>MY942862.1 Sequence 367 from patent US 11279934
GTACCAGTGCACG
>MY942860.1 Sequence 365 from patent US 11279934
CAATGACAACGCC
>MY942858.1 Sequence 363 from patent US 11279934
TTGCGAAGCTGAC
>MY942856.1 Sequence 361 from patent US 11279934
CGAAGCTGACCTG
>MY942854.1 Sequence 359 from patent US 11279934
TGTTCCAAGACCT
>MY942852.1 Sequence 357 from patent US 11279934
CCTATCAAGTTTG
>MY942850.1 Sequence 355 from patent US 11279934
CCGACTGGAAGAC
>MY942848.1 Sequence 353 from patent US 11279934
CTTGCGAAGCTGA
>MY942846.1 Sequence 351 from patent US 11279934
GGCCTTGCGAAGC
>MY942844.1 Sequence 349 from patent US 11279934
CGAGGTCATGAAG
>MY942842.1 Sequence 347 from patent US 11279934
AAGACACGTTTGG
>MY942840.1 Sequence 345 from patent US 11279934
GAGCTAAATTCTG
>MY942838.1 Sequence 343 from patent US 11279934
GGTCAGGCCTTGC
>MY942836.1 Sequence 341 from patent US 11279934
GCTAGAGAAGCAG
>MY942834.1 Sequence 339 from patent US 11279934
TGGAGTATGTACC
>MY942832.1 Sequence 337 from patent US 11279934
GCCAGAACTGCAG
>MY942830.1 Sequence 335 from patent US 11279934
TCAAGTTTGAGCT
>MY942828.1 Sequence 333 from patent US 11279934
TGGTCAGGCCTTG
>MY942826.1 Sequence 331 from patent US 11279934
TGACTTCGGCTCC
>MY942824.1 Sequence 329 from patent US 11279934
GTGACTTCGGCTC
>MY942822.1 Sequence 327 from patent US 11279934
GGAAGATGTACGG
>MY942820.1 Sequence 325 from patent US 11279934
GCGAAGCTGACCT
>MY942818.1 Sequence 323 from patent US 11279934
TCAGGCCTTGCGA
>MY942816.1 Sequence 321 from patent US 11279934
ACGGAGACATGGC
>MY942814.1 Sequence 319 from patent US 11279934
GACACGTTTGGCC
>MY942812.1 Sequence 317 from patent US 11279934
GGCGAGGTCATGA
>MY942810.1 Sequence 315 from patent US 11279934
AATGACAACGCCT
>MY942808.1 Sequence 313 from patent US 11279934
AAGATGTACGGAG
>MY942806.1 Sequence 311 from patent US 11279934
TGGAAGACACGTT
>MY942804.1 Sequence 309 from patent US 11279934
TAAATTCTGTGGA
>MY942802.1 Sequence 307 from patent US 11279934
GAGGTCATGAAGA
>MY942800.1 Sequence 305 from patent US 11279934
ATGACAACGCCTC
>MY942798.1 Sequence 303 from patent US 11279934
CGGAGACATGGCA
>MY942796.1 Sequence 301 from patent US 11279934
TCTGTGGAGTATG
>MY942794.1 Sequence 299 from patent US 11279934
CGAGCTAAATTCT
>MY942792.1 Sequence 297 from patent US 11279934
CAGGCCTTGCGAA
>MY942790.1 Sequence 295 from patent US 11279934
ACCGCAAGATCGG
>MY942788.1 Sequence 293 from patent US 11279934
TACCGACTGGAAG
>MY942786.1 Sequence 291 from patent US 11279934
AGGCCTTGCGAAG
>MY942784.1 Sequence 289 from patent US 11279934
GAAGACACGTTTG
>MY942782.1 Sequence 287 from patent US 11279934
ATGGTCAGGCCTT
>MY942780.1 Sequence 285 from patent US 11279934
GGTCATGAAGAAG
>MY942778.1 Sequence 283 from patent US 11279934
AAGCTGACCTGGA
>MY942776.1 Sequence 281 from patent US 11279934
ATTTGAAGTGTAA
>MY942774.1 Sequence 279 from patent US 11279934
AGTTGTTCCTTAA
>MY942772.1 Sequence 277 from patent US 11279934
AGCAGAAAGGTTA
>MY942770.1 Sequence 275 from patent US 11279934
ACATACCGAGCTA
>MY942768.1 Sequence 273 from patent US 11279934
TTGTTGAGAGTGT
>MY942766.1 Sequence 271 from patent US 11279934
ATACCGAGCTAAA
>MY942764.1 Sequence 269 from patent US 11279934
ATGGCCTTTATTA
>MY942762.1 Sequence 267 from patent US 11279934
GACTGGACAGCTT
>MY942760.1 Sequence 265 from patent US 11279934
TATACGAGTAATA
>MY942758.1 Sequence 263 from patent US 11279934
TTATCTAAGTTAA
>MY942756.1 Sequence 261 from patent US 11279934
TTCTGCTCAGATA
>MY942754.1 Sequence 259 from patent US 11279934
AGCTGATCAGTTT
>MY942752.1 Sequence 257 from patent US 11279934
AGGTAGAATGTAA
>MY942750.1 Sequence 255 from patent US 11279934
AGCTAAATTCTGT
>MY942748.1 Sequence 253 from patent US 11279934
CTATCAAGTTTGA
>MY942746.1 Sequence 251 from patent US 11279934
GGAAGACACGTTT
>MY942744.1 Sequence 249 from patent US 11279934
AGTACCAGTGCAC
>MY942742.1 Sequence 247 from patent US 11279934
CAATGACATCTTT
>MY942740.1 Sequence 245 from patent US 11279934
TTTCAGTAGCACA
>MY942738.1 Sequence 243 from patent US 11279934
AAATTCTGTGGAG
>MY942736.1 Sequence 241 from patent US 11279934
CTGTGGAGTATGT
>MY942734.1 Sequence 239 from patent US 11279934
CAAGTTTGAGCTT
>MY942732.1 Sequence 237 from patent US 11279934
AGCCTATCAAGTT
>MY942730.1 Sequence 235 from patent US 11279934
TGTACGGAGACAT
>MY942728.1 Sequence 233 from patent US 11279934
AATTCTGTGGAGT
>MY942726.1 Sequence 231 from patent US 11279934
GCCTATCAAGTTT
>MY942724.1 Sequence 229 from patent US 11279934
GCTGCGAGGAGTG
>MY942722.1 Sequence 227 from patent US 11279934
GCCTTGCGAAGCT
>MY942720.1 Sequence 225 from patent US 11279934
ATGTACGGAGACA
>MY942718.1 Sequence 223 from patent US 11279934
ACCGACTGGAAGA
>MY942716.1 Sequence 221 from patent US 11279934
AGAGTGGAGCGCC
>MY942714.1 Sequence 219 from patent US 11279934
CATTACAACTGTC
>MY942712.1 Sequence 217 from patent US 11279934
ATTACAACTGTCC
>MY942710.1 Sequence 215 from patent US 11279934
CTGCCATTACAAC
>MY942708.1 Sequence 213 from patent US 11279934
CCATTACAACTGT
>MY942706.1 Sequence 211 from patent US 11279934
CCTGGTCCAGACC
>MY942704.1 Sequence 209 from patent US 11279934
CAGAGTGGAGCGC
>MY942702.1 Sequence 207 from patent US 11279934
AGACCTGTGCCTG
>MY942700.1 Sequence 205 from patent US 11279934
AACTGCCTGGTCC
>MY942698.1 Sequence 203 from patent US 11279934
ACTGGAAGACACG
>MY942696.1 Sequence 201 from patent US 11279934
TGCCATTACAACT
>MY942694.1 Sequence 199 from patent US 11279934
GTTTGAGCTTTCT
>MY942692.1 Sequence 197 from patent US 11279934
TGGAGCGCCTGTT
>MY942690.1 Sequence 195 from patent US 11279934
AGTGGAGCGCCTG
>MY942688.1 Sequence 193 from patent US 11279934
GAGCTTTCTGGCT
>MY942686.1 Sequence 191 from patent US 11279934
GCCATTACAACTG
>MY942684.1 Sequence 189 from patent US 11279934
GGAGCGCCTGTTC
>MY942682.1 Sequence 187 from patent US 11279934
CGACTGGAAGACA
>MY942680.1 Sequence 185 from patent US 11279934
GAGTGGAGCGCCT
>MY942678.1 Sequence 183 from patent US 11279934
ACAGGAAGATGTA
>MY936618.1 Sequence 48 from patent US 11279739
GCAGCAGCAGCAG
>MY935804.1 Sequence 3 from patent US 11278561
AACAGATTGGGAT
>MY935803.1 Sequence 2 from patent US 11278561
TAGGTGTAAGCAA
>MY935802.1 Sequence 1 from patent US 11278561
TAGGGTTAGACAA
>MY935613.1 Sequence 1 from patent US 11278560
CTCTGTATCTTGT
>MY930085.1 Sequence 2 from patent US 11276481
AGGCTGCTACTCT
>MY929998.1 Sequence 4 from patent US 11275081
ATATATGTAAGGC
>MY929953.1 Sequence 118 from patent US 11274351
GAACGCTGGCGGC
>MY928469.1 Sequence 2 from patent US 11274335
GTCGACCGGATCC
>MY917871.1 Sequence 42 from patent US 11274334
CCACGACCAGCCA
>MY915406.1 Sequence 38 from patent US 11274302
GCTGCGTGATGAG
>MY915293.1 Sequence 12 from patent US 11274300
AGAAGTAGCGCCT
>MY915209.1 Sequence 112 from patent US 11274294
ACCCCTCTCCGCT
>MY914649.1 Sequence 36 from patent US 11274144
WATCAANNNNTTR
>MY914001.1 Sequence 21 from patent US 11273214
AAAGTAAGAAAAA
>MY913399.1 Sequence 190 from patent US 11268159
ACCTAAAGTCATG
>MY913285.1 Sequence 75 from patent US 11268159
CCAGTANCAGTNA
>MY913203.1 Sequence 20 from patent US 11268157
GCCGCCRCCATGG
>MY911748.1 Sequence 30 from patent US 11268146
TACACGGACCACA
>MY911747.1 Sequence 29 from patent US 11268146
TACACGGACCGCA
>MY910869.1 Sequence 12 from patent US 11268115
GGTTGGATCCGAT
>MY910858.1 Sequence 1 from patent US 11268115
ATCGGATCCATTT
>MY910558.1 Sequence 21 from patent US 11268106
GGATCCAACCGCC
>MY910384.1 Sequence 67 from patent US 11268099
CNNNNNGNNACCT
>MY910267.1 Sequence 35 from patent US 11268098
TGCATCGATGCAA
>MY909172.1 Sequence 22 from patent US 11268093
GCTGCTCGTGCTG
>MY909171.1 Sequence 21 from patent US 11268093
CTGCTGCTGCTGC
>MY909158.1 Sequence 8 from patent US 11268093
CAGCAGCAGCAGC
>MY909112.1 Sequence 18 from patent US 11268091
AAAAAAANNNNNN
>MY909092.1 Sequence 69 from patent US 11268090
TTTTTTTTTTTTT
>MY906311.1 Sequence 754 from patent US 11268082
GCATGNGGGNGAN
>MY906310.1 Sequence 753 from patent US 11268082
ATCGKAGTAGGAN
>MY901775.1 Sequence 25 from patent US 11266673
CACATTGTCAAGG
>MY901733.1 Sequence 8 from patent US 11266672
TCTGCATCCCCAG
>MY901667.1 Sequence 1272 from patent US 11266655
NTATKCAGYGTNA
>MY901666.1 Sequence 1271 from patent US 11266655
NTATKCAGYGTNA
>MY901621.1 Sequence 1226 from patent US 11266655
RGWATGYTAATKR
>MY901620.1 Sequence 1225 from patent US 11266655
RGWATGYTAATKN
>MY901618.1 Sequence 1223 from patent US 11266655
RGGTGNTAAKCCN
>MY901559.1 Sequence 1164 from patent US 11266655
RTGNKGGCGGAWG
>MY901520.1 Sequence 1125 from patent US 11266655
WTGMATAACAATR
>MY901508.1 Sequence 1113 from patent US 11266655
RTMAACAGGAWRN
>MY901499.1 Sequence 1104 from patent US 11266655
RTAAATANGGGNN
>MY901498.1 Sequence 1103 from patent US 11266655
RTAAATANGGGNN
>MY901494.1 Sequence 1099 from patent US 11266655
RSGTGNNNAACGK
>MY901489.1 Sequence 1094 from patent US 11266655
RSCGGATGTTRTN
>MY901469.1 Sequence 1074 from patent US 11266655
RMATWCCGGAWRN
>MY901386.1 Sequence 991 from patent US 11266655
NNATGAYGCAAYN
>MY901370.1 Sequence 975 from patent US 11266655
NAGGTGNTAATKR
>MY901361.1 Sequence 966 from patent US 11266655
SMGGAAGTMRTTA
>MY901360.1 Sequence 965 from patent US 11266655
RSCGGAWRYATTA
>MY901341.1 Sequence 946 from patent US 11266655
RRAATGCARTAAA
>MY901334.1 Sequence 939 from patent US 11266655
RGAATGCGGAWRT
>MY901316.1 Sequence 921 from patent US 11266655
NNATCATNGTAAA
>MY901308.1 Sequence 913 from patent US 11266655
WMSCGGATGTKNW
>MY901297.1 Sequence 902 from patent US 11266655
RSCGGATGTTKWN
>MY901287.1 Sequence 892 from patent US 11266655
RNMTGATGCAATN
>MY901286.1 Sequence 891 from patent US 11266655
RNCGGATGTTKWN
>MY901280.1 Sequence 885 from patent US 11266655
RCCGGATGTTKWY
>MY901279.1 Sequence 884 from patent US 11266655
RCCGGATGTTKWN
>MY901265.1 Sequence 870 from patent US 11266655
NCCGGATATGCAN
>MY901264.1 Sequence 869 from patent US 11266655
NCCGGATATGCAN
>MY901263.1 Sequence 868 from patent US 11266655
NCCGGATATGCAN
>MY901241.1 Sequence 846 from patent US 11266655
CYCRTAAATWCCN
>MY901231.1 Sequence 836 from patent US 11266655
TMACACMGGAARN
>MY901229.1 Sequence 834 from patent US 11266655
TGTTKATRCGGGN
>MY901214.1 Sequence 819 from patent US 11266655
ANGTGTGAATWCY
>MY901207.1 Sequence 812 from patent US 11266655
TAATKRGGTGYKA
>MY901206.1 Sequence 811 from patent US 11266655
TAATKRGGTGYKA
>MY901204.1 Sequence 809 from patent US 11266655
TAATKAGGTGNKA
>MY901181.1 Sequence 786 from patent US 11266655
TNRCACCGGAAGN
>MY901179.1 Sequence 784 from patent US 11266655
TGTTKMCGGAWRN
>MY901178.1 Sequence 783 from patent US 11266655
TGTTGNCGGAWRN
>MY901177.1 Sequence 782 from patent US 11266655
TGTTGANGCGGGN
>MY901167.1 Sequence 772 from patent US 11266655
GTMAACAGGAWRN
>MY901166.1 Sequence 771 from patent US 11266655
CYAATAAAATGYN
>MY901144.1 Sequence 749 from patent US 11266655
TAATKRNGGATTA
>MY901128.1 Sequence 733 from patent US 11266655
TGTTGCCGGANNN
>MY901127.1 Sequence 732 from patent US 11266655
TCACACCGGAWRY
>MY901125.1 Sequence 730 from patent US 11266655
GGAATGTTAATTR
>MY901122.1 Sequence 727 from patent US 11266655
CTCGTAAAATGYN
>MY901094.1 Sequence 699 from patent US 11266655
NWTGMATAAWTNA
>MY901076.1 Sequence 681 from patent US 11266655
NTRAYNTAATCAN
>MY901027.1 Sequence 632 from patent US 11266655
NWTATGCWAATTW
>MY901008.1 Sequence 613 from patent US 11266655
NTATCGCGAYATR
>MY901007.1 Sequence 612 from patent US 11266655
NTAAYYYAATTAN
>MY901006.1 Sequence 611 from patent US 11266655
NTAAYYNAATTAN
>MY901005.1 Sequence 610 from patent US 11266655
NTAATYTAATTAN
>MY901004.1 Sequence 609 from patent US 11266655
NTAATYTAATTAN
>MY901003.1 Sequence 608 from patent US 11266655
NTAATYNRATTAN
>MY901002.1 Sequence 607 from patent US 11266655
NTAATYNRATTAN
>MY901001.1 Sequence 606 from patent US 11266655
NTAATYNRATTAN
>MY900998.1 Sequence 603 from patent US 11266655
NSCCNNNNNGGSN
>MY900997.1 Sequence 602 from patent US 11266655
NSCCNNNNNGGSN
>MY900996.1 Sequence 601 from patent US 11266655
NSCCNNNNNGGSN
>MY900972.1 Sequence 577 from patent US 11266655
NNATGAYGCAATN
>MY900964.1 Sequence 569 from patent US 11266655
NGGGGAWTCCCCN
>MY900963.1 Sequence 568 from patent US 11266655
NGGGGAWTCCCCN
>MY900962.1 Sequence 567 from patent US 11266655
NGCCNNNNNGGCN
>MY900921.1 Sequence 526 from patent US 11266655
WRTAAAYAAACAA
>MY900917.1 Sequence 522 from patent US 11266655
RTAAACAWMAACA
>MY900835.1 Sequence 440 from patent US 11266655
NNTCCAGATGTKN
>MY900818.1 Sequence 423 from patent US 11266655
NNGCAACAGGTGN
>MY900775.1 Sequence 380 from patent US 11266655
NATATGCTAATKN
>MY900771.1 Sequence 376 from patent US 11266655
NAGGTGTGAAAWN
>MY900768.1 Sequence 373 from patent US 11266655
NACCCGGAAGTAN
>MY900759.1 Sequence 364 from patent US 11266655
DNNNGGTCANNNH
>MY900752.1 Sequence 357 from patent US 11266655
RTAAACATAAACA
>MY900693.1 Sequence 298 from patent US 11266655
TGAATNNNAKTCA
>MY900692.1 Sequence 297 from patent US 11266655
TAATTRCYAATTA
>MY900673.1 Sequence 278 from patent US 11266655
ANRTAAAYAAACA
>MY900655.1 Sequence 260 from patent US 11266655
GTTAATNATTAAY
>MY900625.1 Sequence 230 from patent US 11266655
TTTCAAGGCYCCC
>MY900623.1 Sequence 228 from patent US 11266655
TTCTAGAANNTTC
>MY900622.1 Sequence 227 from patent US 11266655
TTCTAGAANNTTC
>MY900621.1 Sequence 226 from patent US 11266655
TTCTAGAANNTTC
>MY900609.1 Sequence 214 from patent US 11266655
TGAATANCATTCA
>MY900607.1 Sequence 212 from patent US 11266655
TCAATNNNATTGA
>MY900606.1 Sequence 211 from patent US 11266655
TCAATNNCATTGA
>MY900605.1 Sequence 210 from patent US 11266655
TCAATANCATTGA
>MY900574.1 Sequence 179 from patent US 11266655
ATGAATKNYAGTC
>MY900508.1 Sequence 113 from patent US 11266655
TTGCCATGGCAAC
>MY900445.1 Sequence 50 from patent US 11266655
AATTGGCCAATTA
>MY899638.1 Sequence 77 from patent US 11261483
GGCCGATATGCTC
>MY899637.1 Sequence 76 from patent US 11261483
GAGCATATCGGCC
>MY895610.1 Sequence 120 from patent US 11261444
GATAATAAAGTGA
>MY895605.1 Sequence 115 from patent US 11261444
TCACTTTATTATC
>MY895460.1 Sequence 70 from patent US 11261440
NNNTGATGACNNN
>MY895459.1 Sequence 69 from patent US 11261440
NNGTGATGACNNN
>MY895453.1 Sequence 63 from patent US 11261440
NNCCCTCNCCNNN
>MY895452.1 Sequence 62 from patent US 11261440
NNCCCTCGCCNNN
>MY895449.1 Sequence 59 from patent US 11261440
NNCCCTCNCCNNN
>MY895448.1 Sequence 58 from patent US 11261440
NNCCCTCGCCNNN
>MY895447.1 Sequence 57 from patent US 11261440
NNGTGATNACNNN
>MY895446.1 Sequence 56 from patent US 11261440
NNGTNATGACNNN
>MY895445.1 Sequence 55 from patent US 11261440
NNNTGATGACNNN
>MY895444.1 Sequence 54 from patent US 11261440
NNGTGATGACNNN
>MY895423.1 Sequence 33 from patent US 11261440
NNGNGATGACNNN
>MY895422.1 Sequence 32 from patent US 11261440
NNGTGATGACNNN
>MY895411.1 Sequence 21 from patent US 11261440
NNCCCTCGCNNNN
>MY895410.1 Sequence 20 from patent US 11261440
NNCCCTCGNCNNN
>MY895409.1 Sequence 19 from patent US 11261440
NNCCCTNGCCNNN
>MY895408.1 Sequence 18 from patent US 11261440
NNCCCTCGCCNNN
>MY895407.1 Sequence 17 from patent US 11261440
NNGTGATGANNNN
>MY895406.1 Sequence 16 from patent US 11261440
NNGTGATGACNNN
>MY895390.1 Sequence 22 from patent US 11261439
GTTTTAGAGCTAG
>MY893144.1 Sequence 1 from patent US 11261209
GCATTGGTATTCA
>MY892982.1 Sequence 235 from patent US 11260387
CCGACGACCGACG
>MY892740.1 Sequence 49 from patent US 11260134
CTAGGTCATGCGT
>MY892738.1 Sequence 47 from patent US 11260134
TCCTCAGCAATAC
>MY892737.1 Sequence 46 from patent US 11260134
TCCTCAGCAATAC
>MY892735.1 Sequence 44 from patent US 11260134
GTATTGCTGAGGA
>MY892723.1 Sequence 32 from patent US 11260134
CAGTCATGACTTC
>MY892704.1 Sequence 13 from patent US 11260134
CTAGGTCATGCGT
>MY892702.1 Sequence 11 from patent US 11260134
TGAATACCAATGC
>MY892701.1 Sequence 10 from patent US 11260134
GCATTGGTATTCA
>MY892700.1 Sequence 9 from patent US 11260134
GTAGGTCATGCGT
>MY892698.1 Sequence 7 from patent US 11260134
CTAGGTCATGCGT
>MY887663.1 Sequence 425 from patent US 11254989
CCGCAGACTTAGA
>MY887642.1 Sequence 404 from patent US 11254989
CCTGAGGGGCTGT
>MY887633.1 Sequence 395 from patent US 11254989
CGCCAATCTGTCT
>MY887630.1 Sequence 392 from patent US 11254989
CAAGAACCCAGAC
>MY887618.1 Sequence 380 from patent US 11254989
CAGAGGCTCCCAT
>MY887612.1 Sequence 374 from patent US 11254989
GCCTGAACTAAGT
>MY887609.1 Sequence 371 from patent US 11254989
CCCGAGGGTAGAT
>MY887603.1 Sequence 365 from patent US 11254989
TGCCAGACCAATC
>MY887602.1 Sequence 364 from patent US 11254989
CCATCACCACCAC
>MY887593.1 Sequence 355 from patent US 11254989
TCCCTACCAGGAA
>MY887590.1 Sequence 352 from patent US 11254989
TATGTTTGTCCCC
>MY887587.1 Sequence 349 from patent US 11254989
CGCATTAGAGACC
>MY887584.1 Sequence 346 from patent US 11254989
CGCCCAGTCCTAC
>MY887581.1 Sequence 343 from patent US 11254989
CTGGACCAACCCG
>MY887578.1 Sequence 340 from patent US 11254989
TCGGCAGAGGACC
>MY887577.1 Sequence 339 from patent US 11254989
TCGGCAGAGGACC
>MY887569.1 Sequence 331 from patent US 11254989
TGACCTGTTGTGT
>MY887561.1 Sequence 323 from patent US 11254989
AACCATTGAACCC
>MY887552.1 Sequence 314 from patent US 11254989
CACTACAAGACGT
>MY887549.1 Sequence 311 from patent US 11254989
ACGGCAGAATTGA
>MY887546.1 Sequence 308 from patent US 11254989
CGATGAAGCAGAT
>MY887543.1 Sequence 305 from patent US 11254989
TGGAACCTCAGAA
>MY887539.1 Sequence 301 from patent US 11254989
CCTGGTCACAACA
>MY887533.1 Sequence 295 from patent US 11254989
TCCAGTGTCTCTC
>MY887519.1 Sequence 281 from patent US 11254989
AGAGCACACACAT
>MY887513.1 Sequence 275 from patent US 11254989
ACTGACCTATACT
>MY887510.1 Sequence 272 from patent US 11254989
TGTATGTCCTGTT
>MY887504.1 Sequence 266 from patent US 11254989
TTCTCCATACACA
>MY887501.1 Sequence 263 from patent US 11254989
AGAGAAGGCCAGC
>MY887498.1 Sequence 260 from patent US 11254989
AAAGCATCCATGA
>MY887495.1 Sequence 257 from patent US 11254989
CACTACGTCTGTG
>MY887492.1 Sequence 254 from patent US 11254989
TTGCTTGTCCAGC
>MY887489.1 Sequence 251 from patent US 11254989
TGCAAGACTATGT
>MY887486.1 Sequence 248 from patent US 11254989
CGGTGTATGTCCT
>MY887483.1 Sequence 245 from patent US 11254989
TGTCAAAAACCGC
>MY887480.1 Sequence 242 from patent US 11254989
TAGTGTGTATGGA
>MY887474.1 Sequence 236 from patent US 11254989
CGAGGTAGAAGAA
>MY887470.1 Sequence 232 from patent US 11254989
ACCATACAGCAAC
>MY887464.1 Sequence 226 from patent US 11254989
TGACCTATACTGC
>MY887461.1 Sequence 223 from patent US 11254989
CGACATGTGGATT
>MY887460.1 Sequence 222 from patent US 11254989
TTGTGTCCTCAAG
>MY887457.1 Sequence 219 from patent US 11254989
TCTGTATATGGAA
>MY887456.1 Sequence 218 from patent US 11254989
TTCCATATACAGA
>MY887453.1 Sequence 215 from patent US 11254989
TTCCCTCTCTATA
>MY887450.1 Sequence 212 from patent US 11254989
TCCACGCACTGTA
>MY887447.1 Sequence 209 from patent US 11254989
CAGTACAGCAAGT
>MY887446.1 Sequence 208 from patent US 11254989
TGACCTACGAACC
>MY887443.1 Sequence 205 from patent US 11254989
CGGTCCAAGCCTT
>MY887440.1 Sequence 202 from patent US 11254989
ATCCTGAACCAAC
>MY887437.1 Sequence 199 from patent US 11254989
ACACGCCGCACAG
>MY887434.1 Sequence 196 from patent US 11254989
TGTGTCCTCAAGA
>MY887431.1 Sequence 193 from patent US 11254989
CTGTGTTTGCGGT
>MY887428.1 Sequence 190 from patent US 11254989
CGATCTGAGGTAT
>MY887422.1 Sequence 184 from patent US 11254989
TGTACAGAGCACA
>MY887416.1 Sequence 178 from patent US 11254989
AACCTGAGGCAAC
>MY887410.1 Sequence 172 from patent US 11254989
CCGTTGTGTCCAG
>MY887407.1 Sequence 169 from patent US 11254989
TAGTGTGTATGGA
>MY887404.1 Sequence 166 from patent US 11254989
ACGACACACCACA
>MY887398.1 Sequence 160 from patent US 11254989
TAACAGCTCTTGC
>MY887395.1 Sequence 157 from patent US 11254989
CTGGACAAGCAGA
>MY887392.1 Sequence 154 from patent US 11254989
AACTGACCTCCAC
>MY887386.1 Sequence 148 from patent US 11254989
TGTGTCCAGAAGA
>MY887383.1 Sequence 145 from patent US 11254989
ATGGAACAACATT
>MY887380.1 Sequence 142 from patent US 11254989
ACGGAGTGTGTAC
>MY887374.1 Sequence 136 from patent US 11254989
AACTAAGCTCGGC
>MY887371.1 Sequence 133 from patent US 11254989
CAGACGACCTTCG
>MY887365.1 Sequence 127 from patent US 11254989
CTATGTCACGAGC
>MY887362.1 Sequence 124 from patent US 11254989
AGTGCCATTCGTG
>MY887359.1 Sequence 121 from patent US 11254989
TGAATCCAGCAGA
>MY887356.1 Sequence 118 from patent US 11254989
TCAGACTCTGTGT
>MY887350.1 Sequence 112 from patent US 11254989
CACGGAACTGAAC
>MY887347.1 Sequence 109 from patent US 11254989
CTGAACACCCTGT
>MY887341.1 Sequence 103 from patent US 11254989
TCGTTTTCTTCCT
>MY887326.1 Sequence 88 from patent US 11254989
CATGCGGTATACT
>MY887314.1 Sequence 76 from patent US 11254989
ATTTCATCCTCCT
>MY887304.1 Sequence 66 from patent US 11254989
TGTGTCCTGAAGA
>MY887301.1 Sequence 63 from patent US 11254989
TATGGAACAACAT
>MY887289.1 Sequence 51 from patent US 11254989
CACACGTAGACAT
>MY887284.1 Sequence 46 from patent US 11254989
CAGAGCCCATTAC
>MY887281.1 Sequence 43 from patent US 11254989
ACAACTGATCTCT
>MY887278.1 Sequence 40 from patent US 11254989
TCCACCGACCCCT
>MY887269.1 Sequence 31 from patent US 11254989
CGGGATTTATGCA
>MY887263.1 Sequence 25 from patent US 11254989
CTGTGGGTCCTGA
>MY887260.1 Sequence 22 from patent US 11254989
CACACGTAGACAT
>MY887259.1 Sequence 21 from patent US 11254989
AGAGCACACACAT
>MY887256.1 Sequence 18 from patent US 11254989
TGACCTACGAACC
>MY887253.1 Sequence 15 from patent US 11254989
TAACAGCTCTTGC
>MY887250.1 Sequence 12 from patent US 11254989
CAGACGACCTTCG
>MY887244.1 Sequence 6 from patent US 11254989
CACCTCCAGCACC
>MY886760.1 Sequence 24 from patent US 11254982
TAGCACGNGCTAA
>MY886759.1 Sequence 23 from patent US 11254982
TAGCACGNGCTAA
>MY885676.1 Sequence 9 from patent US 11254953
GAAGNNNNNNTAC
>MY885675.1 Sequence 8 from patent US 11254953
GAACNNNNNNTAC
>MY884359.1 Sequence 77 from patent US 11254928
GCTTCTTGGTGGA
>MY861446.1 Sequence 1110 from patent US 11248216
TGAGAAGTGGCAC
>MY861124.1 Sequence 73 from patent US 11248214
GCCGCCNCCATGG
>MY859119.1 Sequence 1 from patent US 11248019
GCATTGGTATTCA
>MY834771.1 Sequence 16327 from patent US 11242525
CTGTTTTGGAATG
>MY812827.1 Sequence 181 from patent US 11241493
GCCGCCACCATGG
>MY812826.1 Sequence 180 from patent US 11241493
GCCGCCACCATGG
>MY808644.1 Sequence 150 from patent US 11237165
GGCCNNNNNGGCC
>MY806490.1 Sequence 47 from patent US 11236400
TGCGCCAATGCAT
>MY801215.1 Sequence 33 from patent US 11235004
GTTGCTCCAGGCC
>MY799563.1 Sequence 1231 from patent US 11230713
ACAAATACGATTA
>MY799468.1 Sequence 1136 from patent US 11230713
ACAAATACGATTA
>MY794214.1 Sequence 11 from patent US 11229699
GGCGCGCCGCACC
>PA565117.1 WO 2022255273-A/4: Ligand-binding nucleic acid complex
TGAATACCAATGC
>PA565116.1 WO 2022255273-A/3: Ligand-binding nucleic acid complex
GCATTGGTATTCA
>PA564759.1 WO 2022250050-A/7: Hetero nucleic acids comprising scpBNA or AmNA
GTTCACTGAATGC
>PA564758.1 WO 2022250050-A/6: Hetero nucleic acids comprising scpBNA or AmNA
GTTCACTGAATGC
>PA564757.1 WO 2022250050-A/5: Hetero nucleic acids comprising scpBNA or AmNA
GCATTCAGTGAAC
>PA564756.1 WO 2022250050-A/4: Hetero nucleic acids comprising scpBNA or AmNA
GTTCACTGAATGC
>pdb|7W7L|D Chain D, Structure of NF-kB p52 homodimer bound to 13-mer A/T-centric P-Selectin kB DNA fragment
AGGGGTTACCCCC
>pdb|7W7L|C Chain C, Structure of NF-kB p52 homodimer bound to 13-mer A/T-centric P-Selectin kB DNA fragment
GGGGGTAACCCCT
>pdb|8H7A|H Chain H, Crystal structure of the dimer form KAT6A WH domain with its bound double stranded DNA
GGTCCGACGGACC
>pdb|8H7A|G Chain G, Crystal structure of the dimer form KAT6A WH domain with its bound double stranded DNA
GGTCCGTCGGACC
>pdb|8H7A|D Chain D, Crystal structure of the dimer form KAT6A WH domain with its bound double stranded DNA
GGTCCGTCGGACC
>pdb|8H7A|C Chain C, Crystal structure of the dimer form KAT6A WH domain with its bound double stranded DNA
GGTCCGACGGACC
>pdb|2AGP|E Chain E, Fidelity of Dpo4: effect of metal ions, nucleotide selection and pyrophosphorolysis
GGGGGAAGGATTN
>pdb|2AGP|C Chain C, Fidelity of Dpo4: effect of metal ions, nucleotide selection and pyrophosphorolysis
GGGGGAAGGATTN
>PA561511.1 WO 2022220141-A/230: Method for detecting mutant SARS-CoV-2
AAGTTTAAAGGCC
>PA561477.1 WO 2022220141-A/196: Method for detecting mutant SARS-CoV-2
CTTTTGGTGAAGT
>PA561442.1 WO 2022220141-A/161: Method for detecting mutant SARS-CoV-2
CCGCCGACGAGAA
>PA561438.1 WO 2022220141-A/157: Method for detecting mutant SARS-CoV-2
CGCCGACGAGAAT
>PA561430.1 WO 2022220141-A/149: Method for detecting mutant SARS-CoV-2
CCGCCGAGGAGAA
>PA561428.1 WO 2022220141-A/147: Method for detecting mutant SARS-CoV-2
CGCCGAGGAGAAT
>PA561414.1 WO 2022220141-A/133: Method for detecting mutant SARS-CoV-2
ATTACCAGTATAG
>PA561413.1 WO 2022220141-A/132: Method for detecting mutant SARS-CoV-2
ATTACCAGTATAG
>PA561342.1 WO 2022220141-A/61: Method for detecting mutant SARS-CoV-2
TGGTGTTCAAGGT
>PA561321.1 WO 2022220141-A/40: Method for detecting mutant SARS-CoV-2
ATGGTGTTGAAGG
>PA561317.1 WO 2022220141-A/36: Method for detecting mutant SARS-CoV-2
TGGTGTTAAAGGT
>PE002129.1 KR 1020220073865-A/14: METHOD FOR REDUCING PRIMER DIMER FORMATION AND INCREASING AMPLIFICATION EFFICIENCY
AGTCGAAAAACAA
>PE002118.1 KR 1020220073865-A/3: METHOD FOR REDUCING PRIMER DIMER FORMATION AND INCREASING AMPLIFICATION EFFICIENCY
AGCTGATATTGTT
>PE001256.1 KR 1020220070579-A/62: MICROFLUIDIC DEVICES AND METHODS FOR USE THEREOF IN MULTICELLULAR ASSAYS OF SECRETION
TTCCAGCTCACAC
>PE001255.1 KR 1020220070579-A/61: MICROFLUIDIC DEVICES AND METHODS FOR USE THEREOF IN MULTICELLULAR ASSAYS OF SECRETION
CACACTCAGAGGG
>PE001254.1 KR 1020220070579-A/60: MICROFLUIDIC DEVICES AND METHODS FOR USE THEREOF IN MULTICELLULAR ASSAYS OF SECRETION
TGAAGCTCTGGAC
>PE001229.1 KR 1020220070579-A/35: MICROFLUIDIC DEVICES AND METHODS FOR USE THEREOF IN MULTICELLULAR ASSAYS OF SECRETION
CAGAGAGCGTGAG
>PE001228.1 KR 1020220070579-A/34: MICROFLUIDIC DEVICES AND METHODS FOR USE THEREOF IN MULTICELLULAR ASSAYS OF SECRETION
GGTGTACAGGTCC
>PE001227.1 KR 1020220070579-A/33: MICROFLUIDIC DEVICES AND METHODS FOR USE THEREOF IN MULTICELLULAR ASSAYS OF SECRETION
TGCTCTGTGACAC
>PE001226.1 KR 1020220070579-A/32: MICROFLUIDIC DEVICES AND METHODS FOR USE THEREOF IN MULTICELLULAR ASSAYS OF SECRETION
GTCCTGAGGACTG
>OF448817.1 KR 1020220025839-A/295: TRANSGENIC MAMMALS AND METHODS OF USE THEREOF
AAATTAATTAACC
>OF448816.1 KR 1020220025839-A/294: TRANSGENIC MAMMALS AND METHODS OF USE THEREOF
CTTCCTTCCTCAG
>OF405886.1 KR 1020220035338-A/119: ENHANCING PRODUCTION OF LENTIVIRAL VECTORS
AAGAGGCGAGGGG
>OF405884.1 KR 1020220035338-A/117: ENHANCING PRODUCTION OF LENTIVIRAL VECTORS
GCAAGAGGCGAGG
>OF405882.1 KR 1020220035338-A/115: ENHANCING PRODUCTION OF LENTIVIRAL VECTORS
CGGCAAGAGGCGA
>OF405880.1 KR 1020220035338-A/113: ENHANCING PRODUCTION OF LENTIVIRAL VECTORS
CACGGCAAGAGGC
>OF405878.1 KR 1020220035338-A/111: ENHANCING PRODUCTION OF LENTIVIRAL VECTORS
CGCACGGCAAGAG
>OF405876.1 KR 1020220035338-A/109: ENHANCING PRODUCTION OF LENTIVIRAL VECTORS
CGCGCACGGCAAG
>OF405872.1 KR 1020220035338-A/105: ENHANCING PRODUCTION OF LENTIVIRAL VECTORS
GAAGCGCGCACGG
>OF405870.1 KR 1020220035338-A/103: ENHANCING PRODUCTION OF LENTIVIRAL VECTORS
CTGAAGCGCGCAC
>OF405868.1 KR 1020220035338-A/101: ENHANCING PRODUCTION OF LENTIVIRAL VECTORS
TGCTGAAGCGCGC
>OF405866.1 KR 1020220035338-A/99: ENHANCING PRODUCTION OF LENTIVIRAL VECTORS
CTTGCTGAAGCGC
>OF405864.1 KR 1020220035338-A/97: ENHANCING PRODUCTION OF LENTIVIRAL VECTORS
GGCTTGCTGAAGC
>OF405862.1 KR 1020220035338-A/95: ENHANCING PRODUCTION OF LENTIVIRAL VECTORS
TCGGCTTGCTGAA
>OF405860.1 KR 1020220035338-A/93: ENHANCING PRODUCTION OF LENTIVIRAL VECTORS
CAGCAAGCCGAGT
>OF405855.1 KR 1020220035338-A/88: ENHANCING PRODUCTION OF LENTIVIRAL VECTORS
GCCGTGCGCGCTT
>OF405754.1 KR 1020220003168-A/11: METHODS AND COMPOSITIONS FOR REDUCING THE IMMUNOGENICITY OF CHIMERIC NOTCH RECEPTORS
GTTAATNATTAAC
>OF405726.1 KR 1020220016199-A/38: ALKALINE PHOSPHATASE FORMULATIONS AND USES THEREOF
GCCGCCACCATGG
>OF448522.1 KR 1020220025838-A/471: TRANSGENIC MAMMALS AND METHODS OF USE
AAATTAATTAACC
>OF448521.1 KR 1020220025838-A/470: TRANSGENIC MAMMALS AND METHODS OF USE
CTTCCTTCCTCAG
>OF448510.1 KR 1020220025838-A/459: TRANSGENIC MAMMALS AND METHODS OF USE
AGGATCCAGTGGG
>OF447946.1 KR 1020220018613-A/52: METHODS FOR BREAKING IMMUNOLOGICAL TOLERANCE USING MULTIPLE GUIDE RNAS
AGGAGGAAAACGC
>OF404553.1 KR 1020220068954-A/7: OPTIMIZED PHENYLALANINE HYDROXYLASE EXPRESSION
GTTAATCATTAAC
>OF403900.1 KR 1020220024160-A/21: COMPOSITIONS AND METHODS FOR PREPARING AN ALZHEIMER'S DISEASE ANIMAL MODEL USING MICRORNA
GTCATACACGGCT
>OF403886.1 KR 1020220024160-A/7: COMPOSITIONS AND METHODS FOR PREPARING AN ALZHEIMER'S DISEASE ANIMAL MODEL USING MICRORNA
TCATACACGGCTC
>OF443673.1 KR 1020220056847-A/32: ENGINEERED ONCOSELECTIVE PROTEIN EXPRESSION
NNNDNKNNSCNWN
>OF443671.1 KR 1020220056847-A/30: ENGINEERED ONCOSELECTIVE PROTEIN EXPRESSION
VMNNWNKNNNNNN
>OF443670.1 KR 1020220056847-A/29: ENGINEERED ONCOSELECTIVE PROTEIN EXPRESSION
VNNNNNNMNNMWK
>OF443669.1 KR 1020220056847-A/28: ENGINEERED ONCOSELECTIVE PROTEIN EXPRESSION
WGNNSNHNHDNNN
>OF443668.1 KR 1020220056847-A/27: ENGINEERED ONCOSELECTIVE PROTEIN EXPRESSION
MWBNNNNNNNNNN
>OF443667.1 KR 1020220056847-A/26: ENGINEERED ONCOSELECTIVE PROTEIN EXPRESSION
DVHVNNNCWNNNB
>OF443666.1 KR 1020220056847-A/25: ENGINEERED ONCOSELECTIVE PROTEIN EXPRESSION
NNNVWNNKGHHNH
>OF443665.1 KR 1020220056847-A/24: ENGINEERED ONCOSELECTIVE PROTEIN EXPRESSION
VNNNNNNMNNMWK
>OF442974.1 KR 1020220013460-A/18: VIRAL RESISTANT CELLS AND USES THEREOF
GCCGCCACCAATG
>OF441357.1 KR 1020220024636-A/23: METHOD FOR THE GENERATION OF A MULTIVALENT, MULTISPECIFIC ANTIBODY EXPRESSING CELL BY TARGETED INTEGRATION OF MULTIPLE EXPRESSION CASSETTES IN A DEFINED ORGANIZATION
TATACGAAGTTAT
>OF441356.1 KR 1020220024636-A/22: METHOD FOR THE GENERATION OF A MULTIVALENT, MULTISPECIFIC ANTIBODY EXPRESSING CELL BY TARGETED INTEGRATION OF MULTIPLE EXPRESSION CASSETTES IN A DEFINED ORGANIZATION
ATAACTTCGTATA
>OF481572.1 KR 1020220053048-A/74: Antisense nucleic acids
GTTTGCCGCTGCC
>OF481571.1 KR 1020220053048-A/73: Antisense nucleic acids
TCCTGGAGTTCCT
>OF481274.1 KR 1020220087441-A/14: IMMUNOTHERAPY COMPOUNDS AND METHODS
TAATAGCTCGAGA
>OF391368.1 KR 1020220010024-A/15: METHOD FOR THE GENERATION OF A PROTEIN EXPRESSING CELL BY TARGETED INTEGRATION USING CRE MRNA
TATACGAAGTTAT
>OF391367.1 KR 1020220010024-A/14: METHOD FOR THE GENERATION OF A PROTEIN EXPRESSING CELL BY TARGETED INTEGRATION USING CRE MRNA
ATAACTTCGTATA
>OF391352.1 KR 1020220010023-A/2: RADIOLABELED MOEM TYPE OLIGONUCLEOTIDES AND PROCESS FOR THEIR PREPARATION
GCATTGGTATTCA
>OF389893.1 KR 1020220012266-A/14: GENE THERAPY VECTORS FOR INFANTILE MALIGNANT OSTEOPETROSIS
GCCGCCRCCATGG
>OF389891.1 KR 1020220012266-A/6: GENE THERAPY VECTORS FOR INFANTILE MALIGNANT OSTEOPETROSIS
GCCGCCACCATGG
>OF387662.1 KR 1020220005560-A/38: ALKALINE PHOSPHATE-BASED ONCOLOGY TREATMENTS
GCCGCCACCATGG
>OF387465.1 KR 1020220002609-A/1015: MODIFICATIONS OF MAMMALIAN CELLS USING ARTIFICIAL MICRO-RNA TO ALTER THEIR PROPERTIES AND THE COMPOSITIONS OF THEIR PRODUCTS
TATCTTTCTAGGG
>OF387464.1 KR 1020220002609-A/1014: MODIFICATIONS OF MAMMALIAN CELLS USING ARTIFICIAL MICRO-RNA TO ALTER THEIR PROPERTIES AND THE COMPOSITIONS OF THEIR PRODUCTS
CCCTAGAAAGATA
>OF471726.1 KR 1020220051401-A/209: GENETICALLY ENGINEERED T CELLS HAVING IMPROVED PERSISTENCE IN CULTURE
TCCTATTGGGTAA
>OF471716.1 KR 1020220051401-A/199: GENETICALLY ENGINEERED T CELLS HAVING IMPROVED PERSISTENCE IN CULTURE
CCTAGTGGGTAAG
>OF471708.1 KR 1020220051401-A/191: GENETICALLY ENGINEERED T CELLS HAVING IMPROVED PERSISTENCE IN CULTURE
CCTATTGGGTAAG
>OF471697.1 KR 1020220051401-A/180: GENETICALLY ENGINEERED T CELLS HAVING IMPROVED PERSISTENCE IN CULTURE
GCTCACCGGTGTG
>OF387184.1 KR 1020220002609-A/712: MODIFICATIONS OF MAMMALIAN CELLS USING ARTIFICIAL MICRO-RNA TO ALTER THEIR PROPERTIES AND THE COMPOSITIONS OF THEIR PRODUCTS
GCTACTGCTAGGC
>OF387181.1 KR 1020220002609-A/709: MODIFICATIONS OF MAMMALIAN CELLS USING ARTIFICIAL MICRO-RNA TO ALTER THEIR PROPERTIES AND THE COMPOSITIONS OF THEIR PRODUCTS
GTCAGCAGTGCCT
>OF387164.1 KR 1020220002609-A/692: MODIFICATIONS OF MAMMALIAN CELLS USING ARTIFICIAL MICRO-RNA TO ALTER THEIR PROPERTIES AND THE COMPOSITIONS OF THEIR PRODUCTS
TGGTCCCCTCCCC
>OF387161.1 KR 1020220002609-A/689: MODIFICATIONS OF MAMMALIAN CELLS USING ARTIFICIAL MICRO-RNA TO ALTER THEIR PROPERTIES AND THE COMPOSITIONS OF THEIR PRODUCTS
TGTTTAGTTATCT
>OF387158.1 KR 1020220002609-A/686: MODIFICATIONS OF MAMMALIAN CELLS USING ARTIFICIAL MICRO-RNA TO ALTER THEIR PROPERTIES AND THE COMPOSITIONS OF THEIR PRODUCTS
CTGGGCTCAGACC
>OF470049.1 KR 1020220051259-A/2: MODULATION OF MICROBIOTA COMPOSITIONS USING TARGETED NUCLEASES
CCTGTCTCTCCGC
>OF469719.1 KR 1020220049619-A/498: SYSTEM FOR REGULATING GENE EXPRESSION
CACACAGATTACG
>OF469718.1 KR 1020220049619-A/497: SYSTEM FOR REGULATING GENE EXPRESSION
CACACAGCATACG
>OF469717.1 KR 1020220049619-A/496: SYSTEM FOR REGULATING GENE EXPRESSION
CACACAGGATACG
>OF469716.1 KR 1020220049619-A/495: SYSTEM FOR REGULATING GENE EXPRESSION
CACACAGAATACG
>OF469689.1 KR 1020220049619-A/468: SYSTEM FOR REGULATING GENE EXPRESSION
ACAGAGATCTGGG
>OF469687.1 KR 1020220049619-A/466: SYSTEM FOR REGULATING GENE EXPRESSION
CACAGATCTGGGG
>OF469650.1 KR 1020220049619-A/429: SYSTEM FOR REGULATING GENE EXPRESSION
TAAAGTATAGTGG
>OF469648.1 KR 1020220049619-A/427: SYSTEM FOR REGULATING GENE EXPRESSION
TAAAGTATGTGGG
>OF469647.1 KR 1020220049619-A/426: SYSTEM FOR REGULATING GENE EXPRESSION
ATACCGTATACTT
>OF469638.1 KR 1020220049619-A/417: SYSTEM FOR REGULATING GENE EXPRESSION
AAAGTATAAGTGG
>OF469633.1 KR 1020220049619-A/412: SYSTEM FOR REGULATING GENE EXPRESSION
AACAAGAGTGCAA
>OF469622.1 KR 1020220049619-A/401: SYSTEM FOR REGULATING GENE EXPRESSION
CCAGGTCTGTGTG
>OF469621.1 KR 1020220049619-A/400: SYSTEM FOR REGULATING GENE EXPRESSION
CACACAGACCTGG
>OF469615.1 KR 1020220049619-A/394: SYSTEM FOR REGULATING GENE EXPRESSION
AAAGTATAGTGCA
>OF469590.1 KR 1020220049619-A/369: SYSTEM FOR REGULATING GENE EXPRESSION
AAGTATAAAGTGT
>OF469589.1 KR 1020220049619-A/368: SYSTEM FOR REGULATING GENE EXPRESSION
GCGTTTTATACTT
>OF469571.1 KR 1020220049619-A/350: SYSTEM FOR REGULATING GENE EXPRESSION
CCAGATCTTCTGC
>OF469570.1 KR 1020220049619-A/349: SYSTEM FOR REGULATING GENE EXPRESSION
GCAGAAGATCTGG
>OF469569.1 KR 1020220049619-A/348: SYSTEM FOR REGULATING GENE EXPRESSION
CCAGATCTTCTGG
>OF469568.1 KR 1020220049619-A/347: SYSTEM FOR REGULATING GENE EXPRESSION
CCAGAAGATCTGG
>OF469567.1 KR 1020220049619-A/346: SYSTEM FOR REGULATING GENE EXPRESSION
CCAGATCGTCTGT
>OF469566.1 KR 1020220049619-A/345: SYSTEM FOR REGULATING GENE EXPRESSION
ACAGACGATCTGG
>OF469565.1 KR 1020220049619-A/344: SYSTEM FOR REGULATING GENE EXPRESSION
CCAGATCTCCTGT
>OF469564.1 KR 1020220049619-A/343: SYSTEM FOR REGULATING GENE EXPRESSION
ACAGGAGATCTGG
>OF469563.1 KR 1020220049619-A/342: SYSTEM FOR REGULATING GENE EXPRESSION
CCAGCTCGCCTGT
>OF469562.1 KR 1020220049619-A/341: SYSTEM FOR REGULATING GENE EXPRESSION
ACAGGCGAGCTGG
>OF469561.1 KR 1020220049619-A/340: SYSTEM FOR REGULATING GENE EXPRESSION
CCAGATCGCCTGT
>OF469560.1 KR 1020220049619-A/339: SYSTEM FOR REGULATING GENE EXPRESSION
ACAGGCGATCTGG
>OF469558.1 KR 1020220049619-A/337: SYSTEM FOR REGULATING GENE EXPRESSION
GCAGAAGATCTGG
>OF469518.1 KR 1020220049619-A/297: SYSTEM FOR REGULATING GENE EXPRESSION
GCTACAAGTACCT
>OF469485.1 KR 1020220049619-A/264: SYSTEM FOR REGULATING GENE EXPRESSION
CTAATAAAGTATA
>OF469483.1 KR 1020220049619-A/262: SYSTEM FOR REGULATING GENE EXPRESSION
TATACTTACACGA
>OF469473.1 KR 1020220049619-A/252: SYSTEM FOR REGULATING GENE EXPRESSION
CCTAATAAAGTAT
>OF469469.1 KR 1020220049619-A/248: SYSTEM FOR REGULATING GENE EXPRESSION
TCGTGATTGGGTG
>OF469468.1 KR 1020220049619-A/247: SYSTEM FOR REGULATING GENE EXPRESSION
TACTTTGATCACG
>OF469466.1 KR 1020220049619-A/245: SYSTEM FOR REGULATING GENE EXPRESSION
TCGTGACTGGTGT
>OF469453.1 KR 1020220049619-A/232: SYSTEM FOR REGULATING GENE EXPRESSION
CTCGTGTCGGGTG
>OF469451.1 KR 1020220049619-A/230: SYSTEM FOR REGULATING GENE EXPRESSION
TACCTTAATAAAG
>OF469441.1 KR 1020220049619-A/220: SYSTEM FOR REGULATING GENE EXPRESSION
TCGTGTCGGGTGT
>OF469417.1 KR 1020220049619-A/196: SYSTEM FOR REGULATING GENE EXPRESSION
CTCGTGAGGGTGT
>OF469413.1 KR 1020220049619-A/192: SYSTEM FOR REGULATING GENE EXPRESSION
TACTTCACACGAG
>OF469409.1 KR 1020220049619-A/188: SYSTEM FOR REGULATING GENE EXPRESSION
CTCGTGAGGGTGT
>OF469404.1 KR 1020220049619-A/183: SYSTEM FOR REGULATING GENE EXPRESSION
TACCTAATAAAGT
>OF469396.1 KR 1020220049619-A/175: SYSTEM FOR REGULATING GENE EXPRESSION
GTACCTAATAAAG
>OF469395.1 KR 1020220049619-A/174: SYSTEM FOR REGULATING GENE EXPRESSION
TCTCGTGAGGGTG
>OF469389.1 KR 1020220049619-A/168: SYSTEM FOR REGULATING GENE EXPRESSION
TACTTCACACGAG
>OF469368.1 KR 1020220049619-A/147: SYSTEM FOR REGULATING GENE EXPRESSION
TACTTTGAACACG
>OF469364.1 KR 1020220049619-A/143: SYSTEM FOR REGULATING GENE EXPRESSION
CTCCTGCCGGGTG
>OF469351.1 KR 1020220049619-A/130: SYSTEM FOR REGULATING GENE EXPRESSION
AGTACCTAATAAA
>OF469349.1 KR 1020220049619-A/128: SYSTEM FOR REGULATING GENE EXPRESSION
TTTGGACAGCAGG
>OF469347.1 KR 1020220049619-A/126: SYSTEM FOR REGULATING GENE EXPRESSION
CTCCTGCGGGGTG
>OF469343.1 KR 1020220049619-A/122: SYSTEM FOR REGULATING GENE EXPRESSION
TTTGGACAGCAGG
>OF469335.1 KR 1020220049619-A/114: SYSTEM FOR REGULATING GENE EXPRESSION
GTACCTAATAAAG
>OF469302.1 KR 1020220049619-A/81: SYSTEM FOR REGULATING GENE EXPRESSION
ACCAGATCTTGGG
>OF469301.1 KR 1020220049619-A/80: SYSTEM FOR REGULATING GENE EXPRESSION
ACCAAGATCTGGG
>OF469226.1 KR 1020220049619-A/5: SYSTEM FOR REGULATING GENE EXPRESSION
CTCTGCAGATGTT
>OF469225.1 KR 1020220049619-A/4: SYSTEM FOR REGULATING GENE EXPRESSION
GCGTTTTATACTT
>OF469223.1 KR 1020220049619-A/2: SYSTEM FOR REGULATING GENE EXPRESSION
GGGTGTTTGTGGC
>OF469199.1 KR 1020220052997-A/71: NUCLEIC ACID MEDICINE FOR TARGETING GASTRIC CANCER MOLECULE
GGGCAGACTCCCG
>OF469198.1 KR 1020220052997-A/70: NUCLEIC ACID MEDICINE FOR TARGETING GASTRIC CANCER MOLECULE
GCAGACTCCCGAT
>OF469188.1 KR 1020220052997-A/60: NUCLEIC ACID MEDICINE FOR TARGETING GASTRIC CANCER MOLECULE
CATCTGTTGATTA
>OF469179.1 KR 1020220052997-A/51: NUCLEIC ACID MEDICINE FOR TARGETING GASTRIC CANCER MOLECULE
GCAGTAGTGGAGT
>OF469178.1 KR 1020220052997-A/50: NUCLEIC ACID MEDICINE FOR TARGETING GASTRIC CANCER MOLECULE
AGTAGTGGAGTTT
>OF381124.1 KR 1020220003546-A/1: COMPOUNDS WITH ANTI-TUMOR ACTIVITY AGAINST CANCER CELLS BEARING TYROSINE KINASE INHIBITOR RESISTANT EGFR MUTATIONS
GCAACATCTCCGG
>OF381123.1 KR 1020220004089-A/1: COMPOUNDS AGAINST CANCER BEARING TYROSINE KINASE INHIBITOR RESISTANT EGFR MUTATIONS
GCAACATCTCCGG
>OF379466.1 KR 1020220002882-A/5: COMPOSITIONS AND METHODS FOR TREATING HUNTINGTON'S DISEASE
GCCAGGTAAGTAT
>OF379425.1 KR 1020220010471-A/25: ELECTROCHEMILUMINESCENT LABELED PROBES FOR USE IN IMMUNOASSAY METHODS, METHODS USING SUCH AND KITS COMPRISING SAME
AAGCGTCTTAACT
>OF376072.1 KR 1020220058461-A/26: Composition for targeting cancer cell comprising a strain expressing monomeric streptavidin and a biotinylated compound
TCACACAGGAAAG
>OF375983.1 KR 1020220058460-A/26: A construct expressing monomeric streptavidin
TCACACAGGAAAG
>OF459450.1 KR 1020220047319-A/4: RNA COMBINATIONS AND COMPOSITIONS WITH DECREASED IMMUNOSTIMULATORY PROPERTIES
GCCGCCACCATGG
>OF459449.1 KR 1020220047319-A/3: RNA COMBINATIONS AND COMPOSITIONS WITH DECREASED IMMUNOSTIMULATORY PROPERTIES
GCCGCCACCATGG
>OF374368.1 KR 1020220040983-A/26: Prime editing-based gene editing composition with improved editing efficiency and use thereof
AAGAAGACCTTGA
>OF374367.1 KR 1020220040983-A/25: Prime editing-based gene editing composition with improved editing efficiency and use thereof
AGCTGCCACAAGT
>OF374362.1 KR 1020220040983-A/20: Prime editing-based gene editing composition with improved editing efficiency and use thereof
GATATAACTGAAT
>OF374353.1 KR 1020220040983-A/11: Prime editing-based gene editing composition with improved editing efficiency and use thereof
GACCGGCCTTAGT
>OF372819.1 KR 1020220047502-A/553: An engineered guide RNA for the optimized CRISPR/Cas12f1(Cas14a1) system and use thereof
TTTTATTTTTTTT
>OF372692.1 KR 1020220047502-A/404: An engineered guide RNA for the optimized CRISPR/Cas12f1(Cas14a1) system and use thereof
TTCTTGTTTTATT
>OF372690.1 KR 1020220047502-A/402: An engineered guide RNA for the optimized CRISPR/Cas12f1(Cas14a1) system and use thereof
TTTCTTTATGTTT
>OF372681.1 KR 1020220047502-A/393: An engineered guide RNA for the optimized CRISPR/Cas12f1(Cas14a1) system and use thereof
TTTATTTATTTAT
>OF372629.1 KR 1020220047502-A/341: An engineered guide RNA for the optimized CRISPR/Cas12f1(Cas14a1) system and use thereof
AGNNNNTGAAGGA
>OF372560.1 KR 1020220047502-A/272: An engineered guide RNA for the optimized CRISPR/Cas12f1(Cas14a1) system and use thereof
CAAATTCANNNCN
>OF372540.1 KR 1020220047502-A/252: An engineered guide RNA for the optimized CRISPR/Cas12f1(Cas14a1) system and use thereof
ATAAAGTGGAGAA
>OF372490.1 KR 1020220047502-A/202: An engineered guide RNA for the optimized CRISPR/Cas12f1(Cas14a1) system and use thereof
CAAATTCANNNNV
>OF372481.1 KR 1020220047502-A/193: An engineered guide RNA for the optimized CRISPR/Cas12f1(Cas14a1) system and use thereof
CAAATTCANNNVN
>OF372472.1 KR 1020220047502-A/184: An engineered guide RNA for the optimized CRISPR/Cas12f1(Cas14a1) system and use thereof
CAAATTCANNVNN
>OF372463.1 KR 1020220047502-A/175: An engineered guide RNA for the optimized CRISPR/Cas12f1(Cas14a1) system and use thereof
CAAATTCANVNNN
>OF372453.1 KR 1020220047502-A/165: An engineered guide RNA for the optimized CRISPR/Cas12f1(Cas14a1) system and use thereof
CAAATTCAVNNNN
>OF372452.1 KR 1020220047502-A/164: An engineered guide RNA for the optimized CRISPR/Cas12f1(Cas14a1) system and use thereof
CAAATTCANNNNC
>OF456480.1 KR 1020220028183-A/49: MICRORNA COMPOUNDS AND METHODS FOR MODULATING MIR-21 ACTIVITY
AATCTAATAAGCT
>OF456479.1 KR 1020220028183-A/48: MICRORNA COMPOUNDS AND METHODS FOR MODULATING MIR-21 ACTIVITY
CAATCTAATAAGC
>OF456474.1 KR 1020220028183-A/43: MICRORNA COMPOUNDS AND METHODS FOR MODULATING MIR-21 ACTIVITY
ATCTAATAAGCTA
>OF456466.1 KR 1020220028183-A/35: MICRORNA COMPOUNDS AND METHODS FOR MODULATING MIR-21 ACTIVITY
AGTCTGATAAGCT
>OF456465.1 KR 1020220028183-A/34: MICRORNA COMPOUNDS AND METHODS FOR MODULATING MIR-21 ACTIVITY
CAGTCTGATAAGC
>OF456452.1 KR 1020220028183-A/21: MICRORNA COMPOUNDS AND METHODS FOR MODULATING MIR-21 ACTIVITY
GTCTGATAAGCTA
>OF369501.1 KR 1020220080460-A/4: Method and Kit for Identifying the serotype of Actinobacillus pleuropneumoniae causing pneumonia in Pigs using PNA probe
CTGGGATGTGAGG
>OF369498.1 KR 1020220080460-A/1: Method and Kit for Identifying the serotype of Actinobacillus pleuropneumoniae causing pneumonia in Pigs using PNA probe
GCCACCACAGCCA
>OF369330.1 KR 1020220078371-A/5: COMPOSITION FOR DETECTING PARALITHODES GENUS AND CHIONOECETES GENUS
CGCGTATAGAATC
>OF369329.1 KR 1020220078371-A/4: COMPOSITION FOR DETECTING PARALITHODES GENUS AND CHIONOECETES GENUS
GCGCACGGGTGCG
>OF369325.1 KR 1020220078362-A/7: COMPOSITION FOR DETECTING CEPHALOPOD
CCTTGCCGGAGCA
>OF369322.1 KR 1020220078362-A/4: COMPOSITION FOR DETECTING CEPHALOPOD
CCTTGCCGGAGCA
>OF368868.1 KR 1020220073327-A/29: Primer set for multiplex loop-mediated isothermal amplification reaction for detection and identification of Candida albicans, Candida auris and Candida glabrata using fluorescent probe
GCGGTGGCGTTGC
>OF368783.1 KR 1020220071536-A/22: Method and Kits for Amplifying Target Nucleic Acid with High Specificity
CAGCAGTAAATCT
>OF367883.1 KR 1020220047493-A/30: An engineered crRNA for CRISPR/Cas12a system
TTTTATTTCTTTT
>OF367882.1 KR 1020220047493-A/29: An engineered crRNA for CRISPR/Cas12a system
TTTTATTTATTTT
>OF367881.1 KR 1020220047493-A/28: An engineered crRNA for CRISPR/Cas12a system
TCTATGTCTTATT
>OF367877.1 KR 1020220047493-A/24: An engineered crRNA for CRISPR/Cas12a system
TATGTCTTGCTTT
>OF367870.1 KR 1020220047493-A/17: An engineered crRNA for CRISPR/Cas12a system
TTTTGTTTTATTT
>OF367866.1 KR 1020220047493-A/13: An engineered crRNA for CRISPR/Cas12a system
ATTACATTTCTTT
>OF367863.1 KR 1020220047493-A/10: An engineered crRNA for CRISPR/Cas12a system
TTATTTACCTTTG
>OF452673.1 KR 1020220034872-A/26: NOVEL INTERGENIC SEQUENCE REGIONS AND USES THEREOF
ATCATCAAGAACC
>OF363870.1 KR 1020220025587-A/11: Helix 73-derived RNA molecules interacting with Erm protein and methods of use thereof
GCGACAGGACGGA
>OF407776.1 KR 1020220024392-A/21: Composition for detecting antibiotic resistant pathogen of sepsis and uses thereof
ACAGCCAACGGGC
>OF407749.1 KR 1020220024391-A/21: Composition for detecting pathogen of sepsis and uses thereof
ACAGCCAACGGGC
>OF451435.1 KR 1020220031084-A/4: METHOD FOR ASSESSING RISK OF CUTANEOUS ADVERSE DRUG REACTIONS CAUSED BY EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITOR, TEST KIT THEREOF, AND USE THEREOF
GACGGAGCCCCGG
>OF405956.1 KR 1020220035338-A/189: ENHANCING PRODUCTION OF LENTIVIRAL VECTORS
GGGGCGCAAAAAT
>pdb|7QO1|I Chain I, complex of DNA ligase I and FEN1 on PCNA and DNA
NTCGGACTGAACC
>pdb|7QNZ|I Chain I, human Lig1-DNA-PCNA complex reconstituted in absence of ATP
NTCGGACTGAACC
>PA558594.1 WO 2022202952-A/13: Improved nicotinamide phosphoribosyltransferase
GCCGGGATGCTGG
>PA558606.1 WO 2022202952-A/25: Improved nicotinamide phosphoribosyltransferase
GCCGGGATGCTGG
>PA555909.1 WO 2022196245-A/39: SELECTION MARKER EXPRESSION CASSETTE
GCCGCCRCCATGG
>PA555647.1 WO 2022185664-A/7: translation enhancer
GGGCCGGAAAAGA
>PA555499.1 JP 2022134257-A/7: translation enhancer
GGGCCGGAAAAGA
>PA555430.1 JP 2022142155-A/2: ANTIBODY, COMPOSITE COMPRISING THE ANTIBODY, AND APPARATUS AND METHOD USING THE COMPOSITE
GGCCTCTGCGGCC
>PA555429.1 JP 2022142155-A/1: ANTIBODY, COMPOSITE COMPRISING THE ANTIBODY, AND APPARATUS AND METHOD USING THE COMPOSITE
GGCCCAGCCGGCC
>pdb|1T0K|C Chain C, Joint X-ray and NMR Refinement of Yeast L30e-mRNA complex
GACCGGAGTGTCC
>pdb|1LLM|B Chain B, Crystal Structure of a Zif23-GCN4 Chimera Bound to DNA
TCCCACGCGTGGG
>pdb|1LLM|A Chain A, Crystal Structure of a Zif23-GCN4 Chimera Bound to DNA
TCCCACGCGTGGG
>PA555202.1 JP 2022531325-A/1: ENGINEERED CHIMERIC FUSION PROTEIN COMPOSITIONS AND METHODS OF USE THEREOF
WWWTATTTATTTW
>pdb|7QQO|D Chain D, SpCas9 bound to AAVS1 off-target1 DNA substrate
AGGATGGGTATTG
>pdb|5WSG|B Chain B, Cryo-EM structure of the Catalytic Step II spliceosome (C* complex) at 4.0 angstrom resolution
NTAAATTTTTAAG
>pdb|5GMK|B Chain B, Cryo-EM structure of the Catalytic Step I spliceosome (C complex) at 3.4 angstrom resolution
NTAAATTTTTAAG
>pdb|7ZX1|RRR Chain RRR, Crystal structure of Pol theta polymerase domain in complex with compound 22
GCGGCTGTCATTN
>pdb|7ZX1|PPP Chain PPP, Crystal structure of Pol theta polymerase domain in complex with compound 22
GCGGCTGTCATTN
>pdb|7ZX1|NNN Chain NNN, Crystal structure of Pol theta polymerase domain in complex with compound 22
GCGGCTGTCATTN
>pdb|7ZX1|LLL Chain LLL, Crystal structure of Pol theta polymerase domain in complex with compound 22
GCGGCTGTCATTN
>pdb|7ZX1|JJJ Chain JJJ, Crystal structure of Pol theta polymerase domain in complex with compound 22
GCGGCTGTCATTN
>pdb|7ZX1|HHH Chain HHH, Crystal structure of Pol theta polymerase domain in complex with compound 22
GCGGCTGTCATTN
>pdb|7ZX0|RRR Chain RRR, Crystal structure of Pol theta polymerase domain in complex with compound 5
GCGGCTGTCATTN
>pdb|7ZX0|PPP Chain PPP, Crystal structure of Pol theta polymerase domain in complex with compound 5
GCGGCTGTCATTN
>pdb|7ZX0|NNN Chain NNN, Crystal structure of Pol theta polymerase domain in complex with compound 5
GCGGCTGTCATTN
>pdb|7ZX0|LLL Chain LLL, Crystal structure of Pol theta polymerase domain in complex with compound 5
GCGGCTGTCATTN
>pdb|7ZX0|JJJ Chain JJJ, Crystal structure of Pol theta polymerase domain in complex with compound 5
GCGGCTGTCATTN
>pdb|7ZX0|HHH Chain HHH, Crystal structure of Pol theta polymerase domain in complex with compound 5
GCGGCTGTCATTN
>pdb|7ZUS|III Chain III, Crystal structure of ternary complex of Pol theta polymerase domain
GCGGCTGTCATTN
>pdb|7ZUS|GGG Chain GGG, Crystal structure of ternary complex of Pol theta polymerase domain
GCGGCTGTCATTN
>pdb|7ZUS|EEE Chain EEE, Crystal structure of ternary complex of Pol theta polymerase domain
GCGGCTGTCATTN
>pdb|3JB9|Q Chain Q, Cryo-EM structure of the yeast spliceosome at 3.6 angstrom resolution
NTTATACTAACAC
>pdb|2C28|P Chain P, Efficient and High Fidelity Incorporation of dCTP Opposite 7,8- Dihydro-8-oxodeoxyguanosine by Sulfolobus solfataricus DNA Polymerase Dpo4
GGGGGAAGGATTC
>pdb|2BR0|P Chain P, DNA Adduct Bypass Polymerization by Sulfolobus solfataricus Dpo4. Analysis and Crystal Structures of Multiple Base-Pair Substitution and Frameshift Products with the Adduct 1,N2-Ethenoguanine
GGGGGAAGGATTC
>PA551476.1 JP 2022101241-A/21: Nucleic acid amplification method, primer set, probe, and kit for nucleic acid amplification
CTTATCAGACTGA
>pdb|7JPS|G Chain G, ORC-DNA: Human Origin Recognition Complex (ORC) with DNA bound in the core
ATTATATATATAT
>pdb|7JPS|F Chain F, ORC-DNA: Human Origin Recognition Complex (ORC) with DNA bound in the core
ATATATATATAAT
>pdb|8E24|F Chain F, Human DNA polymerase theta in complex with allosteric inhibitor
GCGGCTGTCATTG
>pdb|8E24|C Chain C, Human DNA polymerase theta in complex with allosteric inhibitor
GCGGCTGTCATTG
>pdb|8E23|F Chain F, Human DNA polymerase theta in complex with allosteric inhibitor
GCGGCTGTCATTG
>pdb|8E23|C Chain C, Human DNA polymerase theta in complex with allosteric inhibitor
GCGGCTGTCATTG
>pdb|7N3Y|H Chain H, Crystal Structure of Saccharomyces cerevisiae Apn2 Catalytic Domain E59Q/D222N Mutant in Complex with DNA
CCGAAATTNNNNN
>pdb|7N3Y|G Chain G, Crystal Structure of Saccharomyces cerevisiae Apn2 Catalytic Domain E59Q/D222N Mutant in Complex with DNA
TCCGAAATNNNNN
>pdb|7N3Y|F Chain F, Crystal Structure of Saccharomyces cerevisiae Apn2 Catalytic Domain E59Q/D222N Mutant in Complex with DNA
TCCGAAATNNNNN
>pdb|7N3Y|E Chain E, Crystal Structure of Saccharomyces cerevisiae Apn2 Catalytic Domain E59Q/D222N Mutant in Complex with DNA
TCCGAAATNNNNN
>pdb|7TQW|P Chain P, Kod RSGA incorporating PMT, n+2
NGCGAACTGCGNN
>pdb|7RSS|P Chain P, Kod-RI incorporating DNA, n+2
NGCGAACTGCGAA
>pdb|7RSR|P Chain P, Kod-RI incorporating PMT, n+2
NGCGAACTGCGNN
>PA550951.1 WO 2022138899-A/21: Nucleic acid amplification method, primer set, probe, and kit for nucleic acid amplification method
CTTATCAGACTGA
>PA550507.1 WO 2022124219-A/1: An autoantibody associated with immunoglobulin A nephropathy
AGGTGGAGGCAGC
>PA548410.1 JP 2022095266-A/6: Nucleic acid conatructs, Kits, Detection method and Methods for predicting therapeutic effects
GGTCAGGATGACC
>PA548408.1 JP 2022095266-A/4: Nucleic acid conatructs, Kits, Detection method and Methods for predicting therapeutic effects
GTTGGTCAGATTG
>PA548406.1 JP 2022095266-A/2: Nucleic acid conatructs, Kits, Detection method and Methods for predicting therapeutic effects
ATGCGCGGTCAGA
>pdb|7Z4J|c Chain c, SpCas9 bound to 18-nucleotide complementary DNA substrate in the catalytic state
CGTGATTCCAGCG
>PA547858.1 JP 2022523148-A/82: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
TGCTAGCTGAGGA
>PA547844.1 JP 2022523148-A/68: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
TAGCAGGTAAGCA
>PA547826.1 JP 2022523148-A/50: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GAGCAGGTAAGCT
>PA545205.1 JP 2022073185-A/19: Oligonucleotides for the detection of Influenza viruses
GCTCACCGTGCCC
>pdb|7P8V|D Chain D, The structure of E. coli MutL bound to a 3' resected DNA end
NCAGCTTAGCTTA
>pdb|7UML|R Chain R, Structure of vesicular stomatitis virus (local reconstruction, 3.5 A resolution)
NTTTTTTTTTTTT
>pdb|8DR6|K Chain K, Closed state of RFC:PCNA bound to a nicked dsDNA
NTAGGGGGGGGGA
>pdb|8DR5|L Chain L, Open state of RFC:PCNA bound to a 3' ss/dsDNA junction (DNA2) with NTD
NCCCCCCCCCTTT
>pdb|8DR5|I Chain I, Open state of RFC:PCNA bound to a 3' ss/dsDNA junction (DNA2) with NTD
NTTCGGGGGGGCC
>pdb|8DR4|L Chain L, Open state of RFC:PCNA bound to a 3' ss/dsDNA junction (DNA2) without NTD
NCCCCCCCCCTTT
>pdb|8DR3|L Chain L, Closed state of RFC:PCNA bound to a 3' ss/dsDNA junction (DNA2) with NTD
NCCCCCCCCCTTT
>pdb|8DR3|K Chain K, Closed state of RFC:PCNA bound to a 3' ss/dsDNA junction (DNA2) with NTD
NTAGGGGGGGGGA
>pdb|8DR1|L Chain L, Consensus closed state of RFC:PCNA bound to a 3' ss/dsDNA junction (DNA2)
NCCCCCCCCCTTT
>pdb|8DR1|K Chain K, Consensus closed state of RFC:PCNA bound to a 3' ss/dsDNA junction (DNA2)
NTAGGGGGGGGGA
>pdb|4QTJ|C Chain C, Complex of WOPR domain of Wor1 in Candida albicans with the 13bp dsDNA
AAGTTAAACTTTT
>pdb|4QTJ|B Chain B, Complex of WOPR domain of Wor1 in Candida albicans with the 13bp dsDNA
AAAAGTTTAACTT
>PA544631.1 JP 2022519312-A/82: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
TGCTAGCTGAGGA
>PA544617.1 JP 2022519312-A/68: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
TAGCAGGTAAGCA
>PA544599.1 JP 2022519312-A/50: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GAGCAGGTAAGCT
>PA544509.1 JP 2022519296-A/82: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
TGCTAGCTGAGGA
>PA544495.1 JP 2022519296-A/68: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
TAGCAGGTAAGCA
>PA544477.1 JP 2022519296-A/50: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GAGCAGGTAAGCT
>PA543011.1 JP 2022054158-A/6: Method for testing risk for development of schizophrenia, kit used for the method, and model mammal for schizophrenia
CGCCCCCGCAGCC
>PA543010.1 JP 2022054158-A/5: Method for testing risk for development of schizophrenia, kit used for the method, and model mammal for schizophrenia
CGCCCCTGCAGCC
>pdb|7U19|K Chain K, RFC:PCNA bound to nicked DNA
NACTTAGGTCTGT
>PA540642.1 JP 2022042243-A/13: DNA detection method
AAAGTCGACGGAT
>PA540640.1 JP 2022042243-A/11: DNA detection method
CCCATTCTACATG
>pdb|6LWI|I Chain I, Crystal structure of human NEIL1(P2G, E3Q, R242) bound to duplex DNA containing dihydrothymine (DHT)
TAGACCTGGACGG
>pdb|6LWI|H Chain H, Crystal structure of human NEIL1(P2G, E3Q, R242) bound to duplex DNA containing dihydrothymine (DHT)
CGTCCANGTCTAC
>pdb|6LWI|F Chain F, Crystal structure of human NEIL1(P2G, E3Q, R242) bound to duplex DNA containing dihydrothymine (DHT)
TAGACCTGGACGG
>pdb|6LWI|E Chain E, Crystal structure of human NEIL1(P2G, E3Q, R242) bound to duplex DNA containing dihydrothymine (DHT)
CGTCCANGTCTAC
>pdb|6LWI|C Chain C, Crystal structure of human NEIL1(P2G, E3Q, R242) bound to duplex DNA containing dihydrothymine (DHT)
TAGACCTGGACGG
>pdb|6LWI|B Chain B, Crystal structure of human NEIL1(P2G, E3Q, R242) bound to duplex DNA containing dihydrothymine (DHT)
CGTCCANGTCTAC
>pdb|6LWH|I Chain I, Crystal structure of human NEIL1(P2G, E3Q, K242) bound to duplex DNA containing dihydrothymine (DHT)
TAGACCTGGACGG
>pdb|6LWH|H Chain H, Crystal structure of human NEIL1(P2G, E3Q, K242) bound to duplex DNA containing dihydrothymine (DHT)
CGTCCANGTCTAC
>pdb|6LWH|F Chain F, Crystal structure of human NEIL1(P2G, E3Q, K242) bound to duplex DNA containing dihydrothymine (DHT)
TAGACCTGGACGG
>pdb|6LWH|E Chain E, Crystal structure of human NEIL1(P2G, E3Q, K242) bound to duplex DNA containing dihydrothymine (DHT)
CGTCCANGTCTAC
>pdb|6LWH|C Chain C, Crystal structure of human NEIL1(P2G, E3Q, K242) bound to duplex DNA containing dihydrothymine (DHT)
TAGACCTGGACGG
>pdb|6LWH|B Chain B, Crystal structure of human NEIL1(P2G, E3Q, K242) bound to duplex DNA containing dihydrothymine (DHT)
CGTCCANGTCTAC
>pdb|5YTC|B Chain B, Large fragment of DNA Polymerase I from Thermus aquaticus in a closed ternary complex with the unnatural base M-fC pair with dATP in the active site
GACCACGGCGCNN
>pdb|7SBA|Y Chain Y, Structure of type I-D Cascade bound to a dsDNA target
CACGTTGATTTTT
>pdb|7Z42|V Chain V, Influenza B polymerase with Pol II pSer5 CTD peptide mimic bound in site 2B
NGTAGTAACAAGA
>pdb|7Z42|H Chain H, Influenza B polymerase with Pol II pSer5 CTD peptide mimic bound in site 2B
NGTAGTAACAAGA
>pdb|7Z43|MaM Chain MaM, Influenza B polymerase with Pol II pSer5 CTD peptide mimic bound in site 1B and 2B
NATCTATAATAGC
>pdb|7KUD|A Chain A, Ax2 Domain of VEGF Readthrough Element
GGTTTCGGGAACC
>PA500525.1 JP 2022509221-A/11: T CELL-DIRECTED ANTI-CANCER VACCINES AGAINST COMMENSAL VIRUSES
ACCAGGTCTTCTG
>PA499310.1 JP 2022021924-A/10: agent for suppressing adipogenic differentiation
TTGGGTGGGGAAA
>OF338312.1 KR 1020210127206-A/440: METHODS OF EDITING A DISEASE-ASSOCIATED GENE USING ADENOSINE DEAMINASE BASE EDITORS, INCLUDING FOR THE TREATMENT OF GENETIC DISEASE
TTGACCAATAGCC
>OF337515.1 KR 1020210124362-A/68: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
TAGCAGGTAAGCA
>OF337497.1 KR 1020210124362-A/50: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GAGCAGGTAAGCT
>OF336506.1 KR 1020210123344-A/68: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
TAGCAGGTAAGCA
>OF336488.1 KR 1020210123344-A/50: METHODS AND COMPOSITIONS FOR MODULATING SPLICING
GAGCAGGTAAGCT
>OF334392.1 KR 1020210122801-A/56: LIVER-SPECIFIC INDUCIBLE PROMOTERS AND METHODS OF USE THEREOF
TGAAGAGGTGGCA
>OF334391.1 KR 1020210122801-A/55: LIVER-SPECIFIC INDUCIBLE PROMOTERS AND METHODS OF USE THEREOF
TGGCACAGTGCCA
>OF334224.1 KR 1020210151049-A/560: TREM COMPOSITIONS AND USES THEREOF
TTTCTTCGGAAGC
>OF334216.1 KR 1020210151049-A/552: TREM COMPOSITIONS AND USES THEREOF
TTCCTTCGGGAGC
>OF334208.1 KR 1020210151049-A/544: TREM COMPOSITIONS AND USES THEREOF
TGTCTTAGGACGT
>OF334189.1 KR 1020210151049-A/525: TREM COMPOSITIONS AND USES THEREOF
TGGACTTGTGGTC
>OF334181.1 KR 1020210151049-A/517: TREM COMPOSITIONS AND USES THEREOF
TGCCGTAAGGCGT
>OF334180.1 KR 1020210151049-A/516: TREM COMPOSITIONS AND USES THEREOF
TGCCGAAAGGCGT
>OF334152.1 KR 1020210151049-A/488: TREM COMPOSITIONS AND USES THEREOF
TACTTTGCGGTGT
>OF334142.1 KR 1020210151049-A/478: TREM COMPOSITIONS AND USES THEREOF
CGTCGTAAGACTT
>OF334141.1 KR 1020210151049-A/477: TREM COMPOSITIONS AND USES THEREOF
CGTCAAAGACTTC
>OF334137.1 KR 1020210151049-A/473: TREM COMPOSITIONS AND USES THEREOF
CGGCTCCGCCTTC
>OF334135.1 KR 1020210151049-A/471: TREM COMPOSITIONS AND USES THEREOF
CGCTTCACGGCGT
>OF334132.1 KR 1020210151049-A/468: TREM COMPOSITIONS AND USES THEREOF
CGCCGTAAGGTGT
>OF331820.1 KR 1020210126012-A/18: CAS12A GUIDE RNA MOLECULES AND USES THEREOF
TCTACTTGTAGAT
>OF331817.1 KR 1020210126012-A/15: CAS12A GUIDE RNA MOLECULES AND USES THEREOF
TCTACTTTGTAGA
>OF331392.1 KR 1020210099204-A/29: METHODS FOR MULTIPLEX DETECTION OF ALLELES ASSOCIATED WITH OPHTHALMIC CONDITIONS
TACACGGACCGCA
>OF331393.1 KR 1020210099204-A/30: METHODS FOR MULTIPLEX DETECTION OF ALLELES ASSOCIATED WITH OPHTHALMIC CONDITIONS
TACACGGACCACA
>OF327904.1 KR 1020210108426-A/176: COMPOSITIONS AND METHODS FOR DETECTING PLASMODIUM SPECIES NUCLEIC ACID
CAGATGTCAGAGG
>OF327876.1 KR 1020210108426-A/136: COMPOSITIONS AND METHODS FOR DETECTING PLASMODIUM SPECIES NUCLEIC ACID
CCTAAAATACTTC
>OF327875.1 KR 1020210108426-A/135: COMPOSITIONS AND METHODS FOR DETECTING PLASMODIUM SPECIES NUCLEIC ACID
ATTTTCTGGAGAC
>OF327874.1 KR 1020210108426-A/134: COMPOSITIONS AND METHODS FOR DETECTING PLASMODIUM SPECIES NUCLEIC ACID
AAATACTTCCATG
>OF327872.1 KR 1020210108426-A/132: COMPOSITIONS AND METHODS FOR DETECTING PLASMODIUM SPECIES NUCLEIC ACID
ATTTTCTGGAGAC
>OF327870.1 KR 1020210108426-A/130: COMPOSITIONS AND METHODS FOR DETECTING PLASMODIUM SPECIES NUCLEIC ACID
ACTTTCTCGCTTG
>OF327820.1 KR 1020210125999-A/21: GENE THERAPY VECTORS FOR TREATMENT OF DANON DISEASE
GCCGCCRCCATGG
>OF327672.1 KR 1020210104779-A/18: DIRECT OLIGONUCLEOTIDE SYNTHESIS ON CELLS AND BIOMOLECULES
AAAAAAANNNNNN
>OF327036.1 KR 1020210125990-A/158: ANELLOSOMES FOR DELIVERING PROTEIN REPLACEMENT THERAPEUTIC MODALITIES
GCGGGGGGCTCCG
>OF327029.1 KR 1020210125990-A/151: ANELLOSOMES FOR DELIVERING PROTEIN REPLACEMENT THERAPEUTIC MODALITIES
GCGGGGGGCTCCG
>OF325979.1 KR 1020210102309-A/52: REDUCED AND MINIMAL MANIPULATION MANUFACTURING OF GENETICALLY-MODIFIED CELLS
TTTGCCTTAGTTA
>OF325255.1 KR 1020210099608-A/14: GENE SILENCING VIA GENOME EDITING
CAGCGCAGCACGC
>OF323984.1 KR 1020210110303-A/1: METHODS OF TREATING MYELODYSPLASTIC SYNDROME
TAGGGTTAGACAA
>OF360494.1 KR 1020210158859-A/22: UBE3A GENES AND EXPRESSION CASSETTES AND THEIR USE
TTTTTTATGGCCA
>OF356489.1 KR 1020210149135-A/1: METHOD FOR ASSESSING RISK OF SEVERE CUTANEOUS ADVERSE DRUG REACTIONS CAUSED BY DISEASE-MODULATING ANTIRHEUMATIC DRUGS, TEST KIT THEREOF, AND USE THEREOF
ATGGCGCCCCGGG
>OF355116.1 KR 1020210153632-A/5: COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISORDERS
GCCAGGTAAGTAT
>OF315032.1 KR 1020210091180-A/10615: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAGATG
>OF315019.1 KR 1020210091180-A/10602: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CATCAAGGAAGAT
>OF315006.1 KR 1020210091180-A/10589: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ACATCAAGGAAGA
>OF314993.1 KR 1020210091180-A/10576: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AACATCAAGGAAG
>OF314918.1 KR 1020210091180-A/10501: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATTTCT
>OF314910.1 KR 1020210091180-A/10493: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCATTTC
>OF314902.1 KR 1020210091180-A/10485: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCATTT
>OF314895.1 KR 1020210091180-A/10478: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGCATT
>OF314888.1 KR 1020210091180-A/10471: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGGAAGATGGCAT
>OF314880.1 KR 1020210091180-A/10463: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGGAAGATGGCA
>OF314869.1 KR 1020210091180-A/10452: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGATGGC
>OF314856.1 KR 1020210091180-A/10439: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGATGG
>OF314838.1 KR 1020210091180-A/10421: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CCAGTCGGTAAGT
>OF314829.1 KR 1020210091180-A/10412: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAGTCGGTAAGTT
>OF314819.1 KR 1020210091180-A/10402: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTCGGTAAGTTC
>OF314809.1 KR 1020210091180-A/10392: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGTTCT
>OF314797.1 KR 1020210091180-A/10380: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTTCTG
>OF314784.1 KR 1020210091180-A/10367: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTCTGT
>OF314772.1 KR 1020210091180-A/10355: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCTGTC
>OF314760.1 KR 1020210091180-A/10343: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTGTCC
>OF314748.1 KR 1020210091180-A/10331: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGTCCA
>OF314736.1 KR 1020210091180-A/10319: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTCCAA
>OF314723.1 KR 1020210091180-A/10306: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCCAAG
>OF314710.1 KR 1020210091180-A/10293: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCAAGC
>OF314697.1 KR 1020210091180-A/10280: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGCCCG
>OF314687.1 KR 1020210091180-A/10270: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAGCCC
>OF314675.1 KR 1020210091180-A/10258: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAAGCC
>OF314659.1 KR 1020210091180-A/10242: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAGATG
>OF314646.1 KR 1020210091180-A/10229: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CATCAAGGAAGAT
>OF314633.1 KR 1020210091180-A/10216: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ACATCAAGGAAGA
>OF314620.1 KR 1020210091180-A/10203: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AACATCAAGGAAG
>OF314545.1 KR 1020210091180-A/10128: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATTTCT
>OF314537.1 KR 1020210091180-A/10120: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCATTTC
>OF314529.1 KR 1020210091180-A/10112: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCATTT
>OF314522.1 KR 1020210091180-A/10105: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGCATT
>OF314496.1 KR 1020210091180-A/10079: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGATGGC
>OF314515.1 KR 1020210091180-A/10098: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGGAAGATGGCAT
>OF314507.1 KR 1020210091180-A/10090: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGGAAGATGGCA
>OF314483.1 KR 1020210091180-A/10066: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGATGG
>OF314465.1 KR 1020210091180-A/10048: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CCAGTCGGTAAGT
>OF314456.1 KR 1020210091180-A/10039: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAGTCGGTAAGTT
>OF314446.1 KR 1020210091180-A/10029: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTCGGTAAGTTC
>OF314436.1 KR 1020210091180-A/10019: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGTTCT
>OF314424.1 KR 1020210091180-A/10007: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTTCTG
>OF314411.1 KR 1020210091180-A/9994: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTCTGT
>OF314399.1 KR 1020210091180-A/9982: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCTGTC
>OF314387.1 KR 1020210091180-A/9970: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTGTCC
>OF314375.1 KR 1020210091180-A/9958: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGTCCA
>OF314363.1 KR 1020210091180-A/9946: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTCCAA
>OF314350.1 KR 1020210091180-A/9933: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCCAAG
>OF314337.1 KR 1020210091180-A/9920: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCAAGC
>OF314324.1 KR 1020210091180-A/9907: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGCCCG
>OF314314.1 KR 1020210091180-A/9897: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAGCCC
>OF314302.1 KR 1020210091180-A/9885: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAAGCC
>OF314286.1 KR 1020210091180-A/9869: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAGATG
>OF314273.1 KR 1020210091180-A/9856: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CATCAAGGAAGAT
>OF314260.1 KR 1020210091180-A/9843: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ACATCAAGGAAGA
>OF314247.1 KR 1020210091180-A/9830: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AACATCAAGGAAG
>OF314172.1 KR 1020210091180-A/9755: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATTTCT
>OF314164.1 KR 1020210091180-A/9747: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCATTTC
>OF314156.1 KR 1020210091180-A/9739: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCATTT
>OF314149.1 KR 1020210091180-A/9732: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGCATT
>OF314142.1 KR 1020210091180-A/9725: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGGAAGATGGCAT
>OF314134.1 KR 1020210091180-A/9717: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGGAAGATGGCA
>OF314123.1 KR 1020210091180-A/9706: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGATGGC
>OF314110.1 KR 1020210091180-A/9693: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGATGG
>OF314092.1 KR 1020210091180-A/9675: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CCAGTCGGTAAGT
>OF314083.1 KR 1020210091180-A/9666: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAGTCGGTAAGTT
>OF314073.1 KR 1020210091180-A/9656: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTCGGTAAGTTC
>OF314063.1 KR 1020210091180-A/9646: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGTTCT
>OF314051.1 KR 1020210091180-A/9634: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTTCTG
>OF314038.1 KR 1020210091180-A/9621: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTCTGT
>OF314026.1 KR 1020210091180-A/9609: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCTGTC
>OF314014.1 KR 1020210091180-A/9597: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTGTCC
>OF314002.1 KR 1020210091180-A/9585: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGTCCA
>OF313990.1 KR 1020210091180-A/9573: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTCCAA
>OF313977.1 KR 1020210091180-A/9560: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCCAAG
>OF313964.1 KR 1020210091180-A/9547: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCAAGC
>OF313951.1 KR 1020210091180-A/9534: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGCCCG
>OF313941.1 KR 1020210091180-A/9524: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAGCCC
>OF313929.1 KR 1020210091180-A/9512: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAAGCC
>OF313913.1 KR 1020210091180-A/9496: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAGATG
>OF313900.1 KR 1020210091180-A/9483: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CATCAAGGAAGAT
>OF313887.1 KR 1020210091180-A/9470: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ACATCAAGGAAGA
>OF313874.1 KR 1020210091180-A/9457: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AACATCAAGGAAG
>OF313799.1 KR 1020210091180-A/9382: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATTTCT
>OF313791.1 KR 1020210091180-A/9374: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCATTTC
>OF313783.1 KR 1020210091180-A/9366: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCATTT
>OF313776.1 KR 1020210091180-A/9359: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGCATT
>OF313769.1 KR 1020210091180-A/9352: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGGAAGATGGCAT
>OF313761.1 KR 1020210091180-A/9344: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGGAAGATGGCA
>OF313750.1 KR 1020210091180-A/9333: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGATGGC
>OF313737.1 KR 1020210091180-A/9320: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGATGG
>OF313719.1 KR 1020210091180-A/9302: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CCAGTCGGTAAGT
>OF313710.1 KR 1020210091180-A/9293: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAGTCGGTAAGTT
>OF313700.1 KR 1020210091180-A/9283: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTCGGTAAGTTC
>OF313690.1 KR 1020210091180-A/9273: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGTTCT
>OF313678.1 KR 1020210091180-A/9261: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTTCTG
>OF313665.1 KR 1020210091180-A/9248: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTCTGT
>OF313653.1 KR 1020210091180-A/9236: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCTGTC
>OF313641.1 KR 1020210091180-A/9224: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTGTCC
>OF313629.1 KR 1020210091180-A/9212: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGTCCA
>OF313617.1 KR 1020210091180-A/9200: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTCCAA
>OF313604.1 KR 1020210091180-A/9187: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCCAAG
>OF313591.1 KR 1020210091180-A/9174: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCAAGC
>OF313578.1 KR 1020210091180-A/9161: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGCCCG
>OF313568.1 KR 1020210091180-A/9151: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAGCCC
>OF313556.1 KR 1020210091180-A/9139: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAAGCC
>OF313540.1 KR 1020210091180-A/9123: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAGATG
>OF313527.1 KR 1020210091180-A/9110: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CATCAAGGAAGAT
>OF313514.1 KR 1020210091180-A/9097: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ACATCAAGGAAGA
>OF313501.1 KR 1020210091180-A/9084: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AACATCAAGGAAG
>OF313426.1 KR 1020210091180-A/9009: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATTTCT
>OF313418.1 KR 1020210091180-A/9001: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCATTTC
>OF313410.1 KR 1020210091180-A/8993: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCATTT
>OF313403.1 KR 1020210091180-A/8986: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGCATT
>OF313396.1 KR 1020210091180-A/8979: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGGAAGATGGCAT
>OF313388.1 KR 1020210091180-A/8971: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGGAAGATGGCA
>OF313377.1 KR 1020210091180-A/8960: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGATGGC
>OF313364.1 KR 1020210091180-A/8947: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGATGG
>OF313346.1 KR 1020210091180-A/8929: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CCAGTCGGTAAGT
>OF313337.1 KR 1020210091180-A/8920: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAGTCGGTAAGTT
>OF313327.1 KR 1020210091180-A/8910: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTCGGTAAGTTC
>OF313317.1 KR 1020210091180-A/8900: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGTTCT
>OF313305.1 KR 1020210091180-A/8888: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTTCTG
>OF313292.1 KR 1020210091180-A/8875: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTCTGT
>OF313280.1 KR 1020210091180-A/8863: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCTGTC
>OF313268.1 KR 1020210091180-A/8851: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTGTCC
>OF313256.1 KR 1020210091180-A/8839: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGTCCA
>OF313244.1 KR 1020210091180-A/8827: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTCCAA
>OF313231.1 KR 1020210091180-A/8814: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCCAAG
>OF313218.1 KR 1020210091180-A/8801: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCAAGC
>OF313205.1 KR 1020210091180-A/8788: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGCCCG
>OF313195.1 KR 1020210091180-A/8778: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAGCCC
>OF313183.1 KR 1020210091180-A/8766: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAAGCC
>OF313167.1 KR 1020210091180-A/8750: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAGATG
>OF313053.1 KR 1020210091180-A/8636: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATTTCT
>OF313045.1 KR 1020210091180-A/8628: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCATTTC
>OF313037.1 KR 1020210091180-A/8620: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCATTT
>OF313030.1 KR 1020210091180-A/8613: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGCATT
>OF313023.1 KR 1020210091180-A/8606: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGGAAGATGGCAT
>OF313015.1 KR 1020210091180-A/8598: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGGAAGATGGCA
>OF313004.1 KR 1020210091180-A/8587: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGATGGC
>OF312991.1 KR 1020210091180-A/8574: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGATGG
>OF312973.1 KR 1020210091180-A/8556: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CCAGTCGGTAAGT
>OF312964.1 KR 1020210091180-A/8547: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAGTCGGTAAGTT
>OF312954.1 KR 1020210091180-A/8537: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTCGGTAAGTTC
>OF312944.1 KR 1020210091180-A/8527: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGTTCT
>OF312932.1 KR 1020210091180-A/8515: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTTCTG
>OF312919.1 KR 1020210091180-A/8502: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTCTGT
>OF313128.1 KR 1020210091180-A/8711: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AACATCAAGGAAG
>OF313154.1 KR 1020210091180-A/8737: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CATCAAGGAAGAT
>OF313141.1 KR 1020210091180-A/8724: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ACATCAAGGAAGA
>OF312907.1 KR 1020210091180-A/8490: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCTGTC
>OF312895.1 KR 1020210091180-A/8478: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTGTCC
>OF312883.1 KR 1020210091180-A/8466: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGTCCA
>OF312871.1 KR 1020210091180-A/8454: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTCCAA
>OF312858.1 KR 1020210091180-A/8441: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCCAAG
>OF312845.1 KR 1020210091180-A/8428: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCAAGC
>OF312832.1 KR 1020210091180-A/8415: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGCCCG
>OF312822.1 KR 1020210091180-A/8405: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAGCCC
>OF312810.1 KR 1020210091180-A/8393: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAAGCC
>OF312794.1 KR 1020210091180-A/8377: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAGATG
>OF312781.1 KR 1020210091180-A/8364: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CATCAAGGAAGAT
>OF312768.1 KR 1020210091180-A/8351: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ACATCAAGGAAGA
>OF312755.1 KR 1020210091180-A/8338: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AACATCAAGGAAG
>OF312680.1 KR 1020210091180-A/8263: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATTTCT
>OF312672.1 KR 1020210091180-A/8255: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCATTTC
>OF312663.1 KR 1020210091180-A/8246: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCATTT
>OF312655.1 KR 1020210091180-A/8238: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGCATT
>OF312645.1 KR 1020210091180-A/8228: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGGAAGATGGCAT
>OF312634.1 KR 1020210091180-A/8217: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGGAAGATGGCA
>OF312623.1 KR 1020210091180-A/8206: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGATGGC
>OF312610.1 KR 1020210091180-A/8193: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGATGG
>OF312592.1 KR 1020210091180-A/8175: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CCAGTCGGTAAGT
>OF312583.1 KR 1020210091180-A/8166: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAGTCGGTAAGTT
>OF312573.1 KR 1020210091180-A/8156: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTCGGTAAGTTC
>OF312513.1 KR 1020210091180-A/8096: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTGTCC
>OF312525.1 KR 1020210091180-A/8108: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCTGTC
>OF312501.1 KR 1020210091180-A/8084: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGTCCA
>OF312563.1 KR 1020210091180-A/8146: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGTTCT
>OF312489.1 KR 1020210091180-A/8072: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTCCAA
>OF312551.1 KR 1020210091180-A/8134: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTTCTG
>OF312476.1 KR 1020210091180-A/8059: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCCAAG
>OF312538.1 KR 1020210091180-A/8121: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTCTGT
>OF312463.1 KR 1020210091180-A/8046: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCAAGC
>OF312450.1 KR 1020210091180-A/8033: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGCCCG
>OF312440.1 KR 1020210091180-A/8023: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAGCCC
>OF312428.1 KR 1020210091180-A/8011: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAAGCC
>OF312412.1 KR 1020210091180-A/7995: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAGATG
>OF312399.1 KR 1020210091180-A/7982: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CATCAAGGAAGAT
>OF312386.1 KR 1020210091180-A/7969: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ACATCAAGGAAGA
>OF312373.1 KR 1020210091180-A/7956: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AACATCAAGGAAG
>OF312298.1 KR 1020210091180-A/7881: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATTTCT
>OF312290.1 KR 1020210091180-A/7873: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCATTTC
>OF312281.1 KR 1020210091180-A/7864: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCATTT
>OF312273.1 KR 1020210091180-A/7856: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGCATT
>OF312263.1 KR 1020210091180-A/7846: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGGAAGATGGCAT
>OF312252.1 KR 1020210091180-A/7835: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGGAAGATGGCA
>OF312241.1 KR 1020210091180-A/7824: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGATGGC
>OF312228.1 KR 1020210091180-A/7811: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGATGG
>OF312210.1 KR 1020210091180-A/7793: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CCAGTCGGTAAGT
>OF312201.1 KR 1020210091180-A/7784: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAGTCGGTAAGTT
>OF312191.1 KR 1020210091180-A/7774: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTCGGTAAGTTC
>OF312181.1 KR 1020210091180-A/7764: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGTTCT
>OF312169.1 KR 1020210091180-A/7752: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTTCTG
>OF312156.1 KR 1020210091180-A/7739: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTCTGT
>OF312143.1 KR 1020210091180-A/7726: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCTGTC
>OF312131.1 KR 1020210091180-A/7714: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTGTCC
>OF312119.1 KR 1020210091180-A/7702: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGTCCA
>OF312107.1 KR 1020210091180-A/7690: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTCCAA
>OF312094.1 KR 1020210091180-A/7677: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCCAAG
>OF312081.1 KR 1020210091180-A/7664: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCAAGC
>OF312068.1 KR 1020210091180-A/7651: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGCCCG
>OF312058.1 KR 1020210091180-A/7641: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAGCCC
>OF312046.1 KR 1020210091180-A/7629: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAAGCC
>OF312030.1 KR 1020210091180-A/7613: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAGATG
>OF312017.1 KR 1020210091180-A/7600: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CATCAAGGAAGAT
>OF312004.1 KR 1020210091180-A/7587: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ACATCAAGGAAGA
>OF311991.1 KR 1020210091180-A/7574: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AACATCAAGGAAG
>OF311916.1 KR 1020210091180-A/7499: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATTTCT
>OF311908.1 KR 1020210091180-A/7491: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCATTTC
>OF311899.1 KR 1020210091180-A/7482: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCATTT
>OF311891.1 KR 1020210091180-A/7474: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGCATT
>OF311881.1 KR 1020210091180-A/7464: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGGAAGATGGCAT
>OF311870.1 KR 1020210091180-A/7453: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGGAAGATGGCA
>OF311859.1 KR 1020210091180-A/7442: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGATGGC
>OF311846.1 KR 1020210091180-A/7429: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGATGG
>OF311828.1 KR 1020210091180-A/7411: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CCAGTCGGTAAGT
>OF311819.1 KR 1020210091180-A/7402: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAGTCGGTAAGTT
>OF311809.1 KR 1020210091180-A/7392: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTCGGTAAGTTC
>OF311799.1 KR 1020210091180-A/7382: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGTTCT
>OF311787.1 KR 1020210091180-A/7370: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTTCTG
>OF311774.1 KR 1020210091180-A/7357: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTCTGT
>OF311761.1 KR 1020210091180-A/7344: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCTGTC
>OF311749.1 KR 1020210091180-A/7332: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTGTCC
>OF311737.1 KR 1020210091180-A/7320: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGTCCA
>OF311725.1 KR 1020210091180-A/7308: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTCCAA
>OF311712.1 KR 1020210091180-A/7295: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCCAAG
>OF311699.1 KR 1020210091180-A/7282: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCAAGC
>OF311686.1 KR 1020210091180-A/7269: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGCCCG
>OF311676.1 KR 1020210091180-A/7259: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAGCCC
>OF311664.1 KR 1020210091180-A/7247: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAAGCC
>OF311648.1 KR 1020210091180-A/7231: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAGATG
>OF311635.1 KR 1020210091180-A/7218: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CATCAAGGAAGAT
>OF311622.1 KR 1020210091180-A/7205: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ACATCAAGGAAGA
>OF311609.1 KR 1020210091180-A/7192: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AACATCAAGGAAG
>OF311534.1 KR 1020210091180-A/7117: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATTTCT
>OF311526.1 KR 1020210091180-A/7109: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCATTTC
>OF311517.1 KR 1020210091180-A/7100: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCATTT
>OF311509.1 KR 1020210091180-A/7092: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGCATT
>OF311499.1 KR 1020210091180-A/7082: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGGAAGATGGCAT
>OF311488.1 KR 1020210091180-A/7071: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGGAAGATGGCA
>OF311477.1 KR 1020210091180-A/7060: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGATGGC
>OF311464.1 KR 1020210091180-A/7047: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGATGG
>OF311317.1 KR 1020210091180-A/6900: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCAAGC
>OF311304.1 KR 1020210091180-A/6887: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGCCCG
>OF311294.1 KR 1020210091180-A/6877: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAGCCC
>OF311446.1 KR 1020210091180-A/7029: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CCAGTCGGTAAGT
>OF311282.1 KR 1020210091180-A/6865: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAAGCC
>OF311437.1 KR 1020210091180-A/7020: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAGTCGGTAAGTT
>OF311266.1 KR 1020210091180-A/6849: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAGATG
>OF311427.1 KR 1020210091180-A/7010: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTCGGTAAGTTC
>OF311417.1 KR 1020210091180-A/7000: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGTTCT
>OF311253.1 KR 1020210091180-A/6836: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CATCAAGGAAGAT
>OF311405.1 KR 1020210091180-A/6988: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTTCTG
>OF311240.1 KR 1020210091180-A/6823: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ACATCAAGGAAGA
>OF311392.1 KR 1020210091180-A/6975: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTCTGT
>OF311227.1 KR 1020210091180-A/6810: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AACATCAAGGAAG
>OF311379.1 KR 1020210091180-A/6962: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCTGTC
>OF311367.1 KR 1020210091180-A/6950: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTGTCC
>OF311355.1 KR 1020210091180-A/6938: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGTCCA
>OF311343.1 KR 1020210091180-A/6926: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTCCAA
>OF311330.1 KR 1020210091180-A/6913: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCCAAG
>OF311152.1 KR 1020210091180-A/6735: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATTTCT
>OF311144.1 KR 1020210091180-A/6727: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCATTTC
>OF311135.1 KR 1020210091180-A/6718: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCATTT
>OF311127.1 KR 1020210091180-A/6710: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGCATT
>OF311117.1 KR 1020210091180-A/6700: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGGAAGATGGCAT
>OF311106.1 KR 1020210091180-A/6689: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGGAAGATGGCA
>OF311095.1 KR 1020210091180-A/6678: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGATGGC
>OF311082.1 KR 1020210091180-A/6665: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGATGG
>OF311064.1 KR 1020210091180-A/6647: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CCAGTCGGTAAGT
>OF311055.1 KR 1020210091180-A/6638: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAGTCGGTAAGTT
>OF311045.1 KR 1020210091180-A/6628: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTCGGTAAGTTC
>OF311035.1 KR 1020210091180-A/6618: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGTTCT
>OF311023.1 KR 1020210091180-A/6606: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTTCTG
>OF311010.1 KR 1020210091180-A/6593: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTCTGT
>OF310997.1 KR 1020210091180-A/6580: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCTGTC
>OF310985.1 KR 1020210091180-A/6568: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTGTCC
>OF310973.1 KR 1020210091180-A/6556: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGTCCA
>OF310961.1 KR 1020210091180-A/6544: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTCCAA
>OF310948.1 KR 1020210091180-A/6531: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCCAAG
>OF310935.1 KR 1020210091180-A/6518: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCAAGC
>OF310922.1 KR 1020210091180-A/6505: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGCCCG
>OF310912.1 KR 1020210091180-A/6495: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAGCCC
>OF310900.1 KR 1020210091180-A/6483: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAAGCC
>OF310884.1 KR 1020210091180-A/6467: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAGATG
>OF310871.1 KR 1020210091180-A/6454: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CATCAAGGAAGAT
>OF310858.1 KR 1020210091180-A/6441: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ACATCAAGGAAGA
>OF310845.1 KR 1020210091180-A/6428: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AACATCAAGGAAG
>OF310770.1 KR 1020210091180-A/6353: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATTTCT
>OF310762.1 KR 1020210091180-A/6345: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCATTTC
>OF310753.1 KR 1020210091180-A/6336: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCATTT
>OF310745.1 KR 1020210091180-A/6328: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGCATT
>OF310735.1 KR 1020210091180-A/6318: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGGAAGATGGCAT
>OF310724.1 KR 1020210091180-A/6307: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGGAAGATGGCA
>OF310713.1 KR 1020210091180-A/6296: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGATGGC
>OF310700.1 KR 1020210091180-A/6283: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGATGG
>OF310682.1 KR 1020210091180-A/6265: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CCAGTCGGTAAGT
>OF310673.1 KR 1020210091180-A/6256: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAGTCGGTAAGTT
>OF310663.1 KR 1020210091180-A/6246: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTCGGTAAGTTC
>OF310653.1 KR 1020210091180-A/6236: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGTTCT
>OF310641.1 KR 1020210091180-A/6224: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTTCTG
>OF310628.1 KR 1020210091180-A/6211: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTCTGT
>OF310615.1 KR 1020210091180-A/6198: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCTGTC
>OF310603.1 KR 1020210091180-A/6186: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTGTCC
>OF310591.1 KR 1020210091180-A/6174: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGTCCA
>OF310579.1 KR 1020210091180-A/6162: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTCCAA
>OF310566.1 KR 1020210091180-A/6149: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCCAAG
>OF310553.1 KR 1020210091180-A/6136: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCAAGC
>OF310540.1 KR 1020210091180-A/6123: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGCCCG
>OF310530.1 KR 1020210091180-A/6113: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAGCCC
>OF310518.1 KR 1020210091180-A/6101: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAAGCC
>OF310502.1 KR 1020210091180-A/6085: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAGATG
>OF310489.1 KR 1020210091180-A/6072: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CATCAAGGAAGAT
>OF310476.1 KR 1020210091180-A/6059: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ACATCAAGGAAGA
>OF310463.1 KR 1020210091180-A/6046: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AACATCAAGGAAG
>OF310388.1 KR 1020210091180-A/5971: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATTTCT
>OF310380.1 KR 1020210091180-A/5963: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCATTTC
>OF310372.1 KR 1020210091180-A/5955: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCATTT
>OF310365.1 KR 1020210091180-A/5948: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGCATT
>OF310358.1 KR 1020210091180-A/5941: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGGAAGATGGCAT
>OF310350.1 KR 1020210091180-A/5933: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGGAAGATGGCA
>OF310337.1 KR 1020210091180-A/5920: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGATGGC
>OF310324.1 KR 1020210091180-A/5907: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGATGG
>OF310306.1 KR 1020210091180-A/5889: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CCAGTCGGTAAGT
>OF310297.1 KR 1020210091180-A/5880: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAGTCGGTAAGTT
>OF310287.1 KR 1020210091180-A/5870: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTCGGTAAGTTC
>OF310277.1 KR 1020210091180-A/5860: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGTTCT
>OF310265.1 KR 1020210091180-A/5848: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTTCTG
>OF310252.1 KR 1020210091180-A/5835: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTCTGT
>OF310240.1 KR 1020210091180-A/5823: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCTGTC
>OF310228.1 KR 1020210091180-A/5811: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTGTCC
>OF310216.1 KR 1020210091180-A/5799: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGTCCA
>OF310204.1 KR 1020210091180-A/5787: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTCCAA
>OF310191.1 KR 1020210091180-A/5774: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCCAAG
>OF310178.1 KR 1020210091180-A/5761: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCAAGC
>OF310165.1 KR 1020210091180-A/5748: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGCCCG
>OF310155.1 KR 1020210091180-A/5738: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAGCCC
>OF310114.1 KR 1020210091180-A/5697: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CATCAAGGAAGAT
>OF310101.1 KR 1020210091180-A/5684: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ACATCAAGGAAGA
>OF310088.1 KR 1020210091180-A/5671: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AACATCAAGGAAG
>OF310013.1 KR 1020210091180-A/5596: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATTTCT
>OF310005.1 KR 1020210091180-A/5588: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCATTTC
>OF309997.1 KR 1020210091180-A/5580: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCATTT
>OF309990.1 KR 1020210091180-A/5573: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGCATT
>OF309983.1 KR 1020210091180-A/5566: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGGAAGATGGCAT
>OF309975.1 KR 1020210091180-A/5558: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGGAAGATGGCA
>OF309962.1 KR 1020210091180-A/5545: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGATGGC
>OF309949.1 KR 1020210091180-A/5532: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGATGG
>OF309931.1 KR 1020210091180-A/5514: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CCAGTCGGTAAGT
>OF310143.1 KR 1020210091180-A/5726: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAAGCC
>OF310127.1 KR 1020210091180-A/5710: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAGATG
>OF309922.1 KR 1020210091180-A/5505: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAGTCGGTAAGTT
>OF309912.1 KR 1020210091180-A/5495: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTCGGTAAGTTC
>OF309902.1 KR 1020210091180-A/5485: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGTTCT
>OF309890.1 KR 1020210091180-A/5473: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTTCTG
>OF309877.1 KR 1020210091180-A/5460: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTCTGT
>OF309865.1 KR 1020210091180-A/5448: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCTGTC
>OF309853.1 KR 1020210091180-A/5436: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTGTCC
>OF309841.1 KR 1020210091180-A/5424: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGTCCA
>OF309829.1 KR 1020210091180-A/5412: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTCCAA
>OF309816.1 KR 1020210091180-A/5399: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCCAAG
>OF309803.1 KR 1020210091180-A/5386: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCAAGC
>OF309790.1 KR 1020210091180-A/5373: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGCCCG
>OF309780.1 KR 1020210091180-A/5363: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAGCCC
>OF309768.1 KR 1020210091180-A/5351: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAAGCC
>OF309752.1 KR 1020210091180-A/5335: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAGATG
>OF309739.1 KR 1020210091180-A/5322: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CATCAAGGAAGAT
>OF309726.1 KR 1020210091180-A/5309: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ACATCAAGGAAGA
>OF309713.1 KR 1020210091180-A/5296: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AACATCAAGGAAG
>OF309638.1 KR 1020210091180-A/5221: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATTTCT
>OF309630.1 KR 1020210091180-A/5213: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCATTTC
>OF309622.1 KR 1020210091180-A/5205: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCATTT
>OF309615.1 KR 1020210091180-A/5198: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGCATT
>OF309608.1 KR 1020210091180-A/5191: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGGAAGATGGCAT
>OF309600.1 KR 1020210091180-A/5183: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGGAAGATGGCA
>OF309515.1 KR 1020210091180-A/5098: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCGGTAAGTTCTG
>OF309587.1 KR 1020210091180-A/5170: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGATGGC
>OF309502.1 KR 1020210091180-A/5085: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTCTGT
>OF309574.1 KR 1020210091180-A/5157: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGATGG
>OF309490.1 KR 1020210091180-A/5073: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCTGTC
>OF309478.1 KR 1020210091180-A/5061: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTGTCC
>OF309556.1 KR 1020210091180-A/5139: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CCAGTCGGTAAGT
>OF309547.1 KR 1020210091180-A/5130: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAGTCGGTAAGTT
>OF309466.1 KR 1020210091180-A/5049: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGTCCA
>OF309537.1 KR 1020210091180-A/5120: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTCGGTAAGTTC
>OF309454.1 KR 1020210091180-A/5037: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTCCAA
>OF309527.1 KR 1020210091180-A/5110: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGTTCT
>OF309441.1 KR 1020210091180-A/5024: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCCAAG
>OF309428.1 KR 1020210091180-A/5011: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCAAGC
>OF309415.1 KR 1020210091180-A/4998: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CTGTCCAAGCCCG
>OF309405.1 KR 1020210091180-A/4988: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCTGTCCAAGCCC
>OF309393.1 KR 1020210091180-A/4976: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TTCTGTCCAAGCC
>OF309377.1 KR 1020210091180-A/4960: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ATCAAGGAAGATG
>OF309364.1 KR 1020210091180-A/4947: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CATCAAGGAAGAT
>OF309351.1 KR 1020210091180-A/4934: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
ACATCAAGGAAGA
>OF309338.1 KR 1020210091180-A/4921: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AACATCAAGGAAG
>OF309263.1 KR 1020210091180-A/4846: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGATGGCATTTCT
>OF309255.1 KR 1020210091180-A/4838: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGATGGCATTTC
>OF309247.1 KR 1020210091180-A/4830: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GAAGATGGCATTT
>OF309240.1 KR 1020210091180-A/4823: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGAAGATGGCATT
>OF309233.1 KR 1020210091180-A/4816: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGGAAGATGGCAT
>OF309225.1 KR 1020210091180-A/4808: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGGAAGATGGCA
>OF309212.1 KR 1020210091180-A/4795: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAAGGAAGATGGC
>OF309199.1 KR 1020210091180-A/4782: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TCAAGGAAGATGG
>OF309181.1 KR 1020210091180-A/4764: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CCAGTCGGTAAGT
>OF309172.1 KR 1020210091180-A/4755: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CAGTCGGTAAGTT
>OF309162.1 KR 1020210091180-A/4745: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTCGGTAAGTTC
>OF309152.1 KR 1020210091180-A/4735: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTCGGTAAGTTCT
>OF309127.1 KR 1020210091180-A/4710: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
CGGTAAGTTCTGT
>OF309115.1 KR 1020210091180-A/4698: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GGTAAGTTCTGTC
>OF309103.1 KR 1020210091180-A/4686: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTAAGTTCTGTCC
>OF309091.1 KR 1020210091180-A/4674: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
TAAGTTCTGTCCA
>OF309079.1 KR 1020210091180-A/4662: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AAGTTCTGTCCAA
>OF309066.1 KR 1020210091180-A/4649: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
AGTTCTGTCCAAG
>OF309053.1 KR 1020210091180-A/4636: BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
GTTCTGTCCAAGC
